Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1050.Time spend outdoors in summer,50359,0.0415554579281243,0.0135512711523748,0.0149949664694697,0.0681159493867789,0.00216820507607761
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1060.Time spent outdoors in winter,48150,0.01843822400412,0.0150713648413276,-0.0111016510848821,0.047978099093122,0.221195497147552
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X1070.Time spent watching television (TV),51167,0.0138605366261938,0.0133374094399007,-0.0122807858760117,0.0400018591283992,0.298712380652507
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X1080.Time spent using computer,48191,-0.0127557548363893,0.0134715319534885,-0.0391599574652268,0.0136484477924482,0.343718015570189
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X1090.Time spent driving,45454,-0.00579680151927749,0.0147678328570459,-0.0347417539190875,0.0231481508805325,0.694672409662189
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1160.Sleep duration,52244,-0.00169156136260667,0.0122809910371548,-0.0257623037954301,0.0223791810702168,0.890448516072641
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,36053,-0.0138401762069996,0.0373243549074585,-0.0869959118256182,0.059315559411619,0.710790945024695
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,36053,-0.00765885076599759,0.0411682832130635,-0.088348685863602,0.0730309843316068,0.852420297243997
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,36053,0.016000224991049,0.0436568016873424,-0.0695671063161421,0.10156755629824,0.714002293637994
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,36053,0.00504121691764532,0.0449842601321804,-0.0831279329414284,0.093210366776719,0.910773902826761
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,36053,0.0508191465255219,0.045956276628768,-0.0392551556668635,0.140893448717907,0.26884223352046
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,36053,-0.23273351866674,0.122690038907297,-0.473205994925042,0.00773895759156148,0.0578767654463455
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,36053,-0.0196705485025391,0.144231105718918,-0.302363515711618,0.26302241870654,0.891522866449688
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,36053,-0.0187313753603705,0.0734254841463346,-0.162645324287186,0.125182573566445,0.798647282508052
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,36053,0.010102899242959,0.0557121422025433,-0.0990928994740258,0.119298697959944,0.856104805663734
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,36053,-0.0476241657493912,0.0377231575063487,-0.121561554461835,0.0263132229630521,0.206821015769635
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,36053,0.0648925120797713,0.0586157897078256,-0.0499944357475669,0.17977945990711,0.268294011828312
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,36053,-0.0158766253702156,0.0280502869176495,-0.0708551877288085,0.0391019369883774,0.571406871577476
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,36053,-0.0626516272926812,0.0383582632956391,-0.137833823352134,0.0125305687667715,0.102442260606445
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,36053,0.0373685013434555,0.0608390324506427,-0.0818760022598042,0.156613004946715,0.539089240982566
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,36053,-0.115637144484218,0.0561162660286782,-0.225625025900427,-0.00564926306800888,0.0393690911020839
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,36053,-0.0142660412590243,0.069102718673712,-0.1497073698595,0.121175287341451,0.836447487080806
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,36053,0.0509006256117957,0.0673251027302816,-0.0810565757395562,0.182857826963148,0.449647728703983
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,36053,-0.0381782632167969,0.0430810223463252,-0.122617067015594,0.0462605405820004,0.375540091845295
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,36053,-0.0352902953723986,0.0420526966836848,-0.117713580872421,0.0471329901276236,0.401388374920476
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,36053,0.052935030727324,0.0465925887796882,-0.0383864432808648,0.144256504735513,0.255940552104641
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120040.Fatigue severity over the past week,36059,0.00959772680770328,0.0227129455136838,-0.0349196463991171,0.0541151000145236,0.672623855377303
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120041.Waking unrefreshed severity over the past week,36062,-0.0142585673667012,0.0223591802605226,-0.0580825606773256,0.0295654259439231,0.523685118183256
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120042.Cognitive symptoms severity over the past week,36063,-0.00274010224101478,0.0246939707953656,-0.0511402849999313,0.0456600805179017,0.911649148418481
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120098.Mobility problems today,36064,-0.0505017383591543,0.0263700529605255,-0.102187042161784,0.00118356544347575,0.0555157681650023
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120099.Self-care problems today,36064,-0.100959934750756,0.0398712274921628,-0.179107540635395,-0.0228123288661169,0.0113568832380555
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120100.Problems doing usual activities,36064,-0.0180455363004383,0.0253142139020981,-0.0676613955485505,0.0315703229476739,0.475953567666888
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120101.Pain or discomfort today,36064,-0.0378976549341484,0.0225202688860445,-0.0820373819507957,0.00624207208249895,0.0924509564144172
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120102.Anxiety or depression today,36064,0.00107377311704937,0.0288112683740285,-0.0553963128960464,0.0575438591301452,0.970271354974382
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120103.Scale to indicate how health is today,36047,0.0193445040972957,0.0122639884261361,-0.00469291321793105,0.0433819214125225,0.114759326613671
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,36049,-0.0195920755085747,0.0281428152557376,-0.0747519934098204,0.0355678423926711,0.486346506289208
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",36048,-0.0268019275427602,0.0299852034184527,-0.0855729262429275,0.0319690711574071,0.371437226087198
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",36053,-0.00537708696555585,0.0228218646570352,-0.0501079416933449,0.0393537677622332,0.813740855498364
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,36057,-0.0182586086334019,0.0231310064028958,-0.0635953811830778,0.0270781639162739,0.429928817137635
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,36057,-0.0564188302131879,0.0333945174089178,-0.121872084334667,0.00903442390829091,0.0911723864121925
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120109.Feeling bad about self over the last two weeks,36041,-0.010247357966361,0.0316145222770344,-0.0722118216293484,0.0517171056966265,0.74584530710386
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120110.Trouble concentrating over the last two weeks,36060,-0.00543398148017455,0.0302307180644681,-0.064686188886532,0.0538182259261829,0.857353464346173
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,36051,-0.0628635349264122,0.0441216101052071,-0.149341890732618,0.0236148208797937,0.15426304470001
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,36017,-0.0513914293080946,0.0611018611799708,-0.171151077220837,0.0683682186046481,0.400331378054235
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33242,-0.0315605357663477,0.0319706521502356,-0.0942230139808095,0.0311019424481141,0.323609750561028
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49713,0.0416391920175138,0.0300304305705999,-0.017220451900862,0.10049883593589,0.165588599801065
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,48481,0.0590291969413713,0.0171864402004502,0.0253437741484889,0.0927146197342538,0.000594557192280785
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1289.Cooked vegetable intake,51298,0.0110070018460508,0.0128487750718978,-0.0141765972948688,0.0361906009869704,0.391643142440149
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50458,-0.0136439300644868,0.0132601592107533,-0.0396338421175632,0.0123459819885896,0.303518482253374
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1309.Fresh fruit intake,51165,-0.026858694896451,0.0135895729957382,-0.0534942579680979,-0.000223131824804088,0.0481194611279435
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1319.Dried fruit intake,50166,-0.0306274078155341,0.0144122416024989,-0.058875401356432,-0.00237941427463613,0.0335898778247988
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X134.Number of self-reported cancers,52395,-0.0222293070638476,0.0269268078468002,-0.075005850443576,0.0305472363158808,0.409070196962109
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X135.Number of self-reported non-cancer illnesses,52396,0.02321166388983,0.0127704145309435,-0.00181834859081935,0.0482416763704793,0.0691359644177283
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X136.Number of operations, self-reported",52396,-0.0134783841257586,0.0123202202284293,-0.03762601577348,0.0106692475219629,0.273963802848803
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X137.Number of treatments or medications taken,52396,0.00699829831129137,0.0125027905133234,-0.0175071710948226,0.0315037677174053,0.575662808011057
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1438.Bread intake,51848,-0.00759518361997226,0.00662685497651271,-0.0205838193739372,0.00539345213399264,0.251756513831004
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1458.Cereal intake,51183,-0.0288019059794186,0.0127892219194412,-0.0538687809415234,-0.00373503101731375,0.0243289808990275
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1488.Tea intake,51518,0.00999383614261532,0.00650411654457238,-0.00275423228474654,0.0227419045699772,0.124419765921235
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1498.Coffee intake,50544,0.00932750223556043,0.0127784727189621,-0.0157183042936052,0.0343733087647261,0.465435424964878
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1528.Water intake,50239,-0.0245343206974704,0.0129626572345031,-0.0499411288770964,0.00087248748215563,0.0584121431788835
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1568.Average weekly red wine intake,46727,-0.0295598882450272,0.0140936631934315,-0.0571834681041529,-0.00193630838590159,0.0359730061394649
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,46717,-0.0154949481957788,0.0146838256738822,-0.044275246516588,0.0132853501250304,0.291330020784313
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1588.Average weekly beer plus cider intake,46792,0.0240314589753117,0.0147007290963304,-0.00478197005349591,0.0528448880041193,0.102126728477488
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1598.Average weekly spirits intake,46720,-0.0153454925204274,0.0152510242366078,-0.0452375000241786,0.0145465149833239,0.314335586163752
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1608.Average weekly fortified wine intake,46759,-0.00562325701302346,0.0272344665261849,-0.0590028114043458,0.0477562973782989,0.836421617135102
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1737.Childhood sunburn occasions,46112,-0.0147100109377838,0.0150110121815642,-0.0441315948136495,0.014711572938082,0.327125339790873
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X1807.Father's age at death,46319,-0.0022457371347314,0.00749779137080621,-0.0169414082215116,0.0124499339520488,0.76454696340516
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X1845.Mother's age,37375,0.0126467011343697,0.0173303343605009,-0.021320754212212,0.0466141564809515,0.465566384558644
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X1873.Number of full brothers,51982,0.0223228499523795,0.0123222188224607,-0.00182869893964339,0.0464743988444024,0.0700618749607949
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X1883.Number of full sisters,51985,0.0134884031833641,0.0123587003892993,-0.0107346495796626,0.0377114559463908,0.275103973021239
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X20015.Sitting height,52183,-0.0369906093145316,0.00853999637659607,-0.0537290022126599,-0.0202522164164033,1.48738777907353e-05
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20016.Fluid intelligence score,36206,-0.0140675970097975,0.0211000641095022,-0.0554237226644218,0.0272885286448268,0.504978454356365
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20018.Prospective memory result,36555,0.00842975260606255,0.0280670843967038,-0.0465817328114768,0.0634412380236019,0.763923378713951
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),36115,0.00743498004339166,0.011274289931809,-0.0146626282229541,0.0295325883097374,0.509618535930036
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),36121,0.0131422659092006,0.011323968989558,-0.00905271331033313,0.0353372451287344,0.24585338859259
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20023.Mean time to correctly identify matches,52085,-0.00220326633136054,0.00671490835526082,-0.0153644867076717,0.0109579540449507,0.742827167781311
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#1.Illnesses of father_Heart disease,48917,0.00227995224293451,0.0149584432898649,-0.0270385966052006,0.0315985010910696,0.878857918606856
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48473,-0.064258498615261,0.0336046680073302,-0.130123647909628,0.00160665067910613,0.0558662342853481
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48433,-0.0324583347064811,0.0442687551697196,-0.119225094839132,0.0543084254261694,0.463438462123429
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#12.Illnesses of father_Severe depression,48458,0.0547015450459994,0.0396174900247782,-0.0229487354025658,0.132351825494565,0.167373743834777
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48480,0.048055755055959,0.0264857423939775,-0.00385630003623686,0.0999678101481549,0.0696310922562195
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#2.Illnesses of father_Stroke,48657,0.0181571619809289,0.0190441591184993,-0.0191693898913297,0.0554837138531876,0.340386679771629
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48601,0.00388952115182306,0.0241231145486618,-0.0433917833635541,0.0511708256672002,0.871908939391289
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48494,-0.000850895992233604,0.0293175744760595,-0.0583133419653101,0.0566115499808429,0.976846210888556
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48622,0.00986502858508558,0.0226453104993945,-0.0345197799937275,0.0542498371638987,0.663108231708631
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48711,0.0139992593254601,0.0169131392175337,-0.0191504935409059,0.0471490121918261,0.407841733771961
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48564,-0.0223305898035402,0.0232699952297923,-0.067939780453933,0.0232786008468527,0.337252993763341
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49721,-0.00858867990315163,0.0178197070872543,-0.0435153057941701,0.0263379459878668,0.629827640448054
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49562,0.0590054621660287,0.0249652204477097,0.0100736300885177,0.10793729424354,0.0181119773678329
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49482,0.0264444826182433,0.0556626525522128,-0.0826543163840937,0.13554328162058,0.634731469303276
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49517,0.0309866567545656,0.0295798844914181,-0.026989916848614,0.0889632303577451,0.29485421208708
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#2.Illnesses of mother_Stroke,49661,-0.00613462642640802,0.0200235995284826,-0.0453808815022339,0.0331116286494179,0.759326118851935
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49557,0.0159066657861314,0.0334655856516312,-0.0496858820910656,0.0814992136633285,0.634568041720564
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49524,-0.0385338322173559,0.0304276749932917,-0.0981720752042076,0.0211044107694959,0.205381367298903
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49533,0.0304150521632827,0.0254674168824697,-0.0195010849263578,0.0803311892529233,0.232384669684791
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49570,-0.0118414675835021,0.030374153515859,-0.0713748084745858,0.0476918733075816,0.696648899821018
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49769,-0.00477810396967978,0.0153251728955206,-0.0348154428449002,0.0252592349055406,0.755209725674419
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49619,0.0162462274683404,0.0230154923799836,-0.0288641375964274,0.0613565925331082,0.48026919214768
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46641,0.00583414126874734,0.024483501653577,-0.0421535219722636,0.0538218045097583,0.81165990756174
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46494,0.0516799158269393,0.0999653030917943,-0.144252078232978,0.247611909886856,0.605177533384381
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46486,-0.00519556422422207,0.097920255828776,-0.197119265648623,0.186728137200179,0.957685382440614
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46542,-0.0582721934624403,0.0320901424016252,-0.121168872569626,0.00462448564474498,0.0694038123343376
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46503,0.0103054436250421,0.0568778334237229,-0.101175109885455,0.121785997135539,0.856223958471449
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46536,0.0540098061902434,0.0409313425927395,-0.026215625291526,0.134235237672013,0.187011509818592
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46509,0.0775754533022972,0.0471428956239635,-0.0148246221206713,0.169975528725266,0.0998763428819652
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46513,-0.0464960530028755,0.0455765872317938,-0.135826163977191,0.0428340579714404,0.307659685254963
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46519,-0.0146385582268351,0.0361974328715028,-0.0855855266549806,0.0563084102013105,0.685917000802163
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46537,-0.00845378184356771,0.0457546616923012,-0.098132918760478,0.0812253550733426,0.853416790969607
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46708,-0.00988214562795056,0.0186361269065511,-0.0464089543647907,0.0266446631088895,0.595932487669469
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46603,-0.019387280731542,0.0259564415188952,-0.0702619061085765,0.0314873446454925,0.455124038758583
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20127.Neuroticism score,47772,-0.00672122574198109,0.0128185280614732,-0.0318455407424685,0.0184030892585063,0.600050384102742
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,36206,-0.00848244709151885,0.0212809179020313,-0.0501930461795002,0.0332281519964625,0.690203557139808
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X20161.Pack years of smoking,36895,0.0187490985444818,0.0113909260224754,-0.00357711645956997,0.0410753135485336,0.0998082534592618
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,36895,0.018809300785015,0.0112287039018506,-0.00319895886261225,0.0408175604326422,0.0939505782946862
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20191.Fluid intelligence score,34263,0.00488017603738211,0.0235603842049893,-0.0412981770043969,0.0510585290791611,0.83591202934481
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34264,0.00911682367091543,0.0240322710421762,-0.03798642757175,0.0562200749135808,0.704436613976353
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20240.Maximum digits remembered correctly,33724,-0.0133813101188515,0.025562103457277,-0.0634830328951144,0.0367204126574114,0.600661300118645
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X20255.Spirometry QC measure,45591,0.0230591093527759,0.0157060821606669,-0.00772481168213117,0.0538430303876829,0.142078104109511
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X20261.avMSE,33821,-0.0123215836781393,0.0138312207588559,-0.0394307763654969,0.0147876090092183,0.373049119464766
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X20262.Myopia diagnosis,33821,0.0256355083470936,0.0322228920016567,-0.0375213599761535,0.0887923766703406,0.426319227267878
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X20280.Glucose-lactate,42158,0.0768457771905317,0.00834696499735605,0.0604857257957138,0.0932058285853495,3.85877055586372e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X20281.Spectrometer-corrected alanine,42182,0.0929911077159513,0.00881365996220337,0.0757163341900327,0.11026588124187,6.34538408147499e-26
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,35953,0.044039755791336,0.0548094321749144,-0.0633867312714962,0.151466242854168,0.421707795648132
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,35953,0.10679748382671,0.120836535971344,-0.130042126677124,0.343637094330544,0.376823461224405
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),35953,0.156535939872366,0.146688789692674,-0.130974087925275,0.444045967670007,0.285948381579993
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),35953,-0.00511346650709645,0.0531357190329312,-0.109259475811642,0.0990325427974487,0.923337294980539
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),35953,0.0193943563670157,0.0756418615456659,-0.12886369226249,0.167652404996521,0.797651375051044
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,35956,0.107465457072697,0.10289931215603,-0.0942171947531215,0.309148108898516,0.29634629822196
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,35956,0.0763365175635029,0.0644548959829513,-0.0499950785630816,0.202668113690087,0.236316729160235
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,35956,-0.0115960159105,0.074157758838786,-0.156945223234521,0.133753191413521,0.875746022889415
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,35956,-0.0446072652392526,0.108247875803985,-0.256773101815063,0.167558571336558,0.680289541058033
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,35956,-0.00618479646034574,0.119963645911358,-0.241313542446607,0.228943949525915,0.958884206699351
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,35956,0.0726205001933979,0.0777718765304231,-0.0798123778062313,0.225053378193027,0.350456811727327
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,35956,0.0829941454950241,0.11749914466395,-0.147304178046317,0.313292469036365,0.480000154653464
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,35956,-0.0234691603089107,0.0945253548087843,-0.208738855734128,0.161800535116306,0.803921386354092
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),35959,0.373170173705529,0.158974976646812,0.0615792194777774,0.68476112793328,0.0189337536526075
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),35959,0.0692914418713822,0.0700997185029664,-0.0681040063944319,0.206686890137196,0.32295520609873
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),35959,0.00337102202731867,0.0926661588357329,-0.178254649290718,0.184996693345355,0.970981835146501
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,35959,0.0950059241190957,0.194878893908825,-0.286956707942201,0.476968556180393,0.625909609532294
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20600.Liking for adding salt to foods,36661,-0.0108314131912665,0.0198843921775,-0.0498048218591665,0.0281419954766334,0.585961639436726
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20601.Liking for aniseed,36661,-0.00449105636913519,0.0198956251938657,-0.0434864817491119,0.0345043690108415,0.821416492136518
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20602.Liking for apple juice,36661,0.00324091052506465,0.0199325306730412,-0.0358268495940961,0.0423086706442254,0.870842166486107
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20603.Liking for apples,36661,-0.00809138863082711,0.0204236314617305,-0.0481217062958189,0.0319389290341647,0.691984392082228
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20604.Liking for asparagus,36661,0.00693837103525361,0.0200113612646656,-0.032283897043491,0.0461606391139982,0.728809547672604
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20605.Liking for aubergine,36661,-0.0514579300653817,0.0199307338529254,-0.0905221684171155,-0.0123936917136478,0.00984506907850497
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20606.Liking for avocados,36661,-0.00624037332261457,0.0199055824098222,-0.045255314845866,0.0327745682006369,0.753909962384892
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20607.Liking for bacon,36661,0.00804386317976355,0.0203442852691525,-0.0318309359477754,0.0479186623073025,0.692567875343977
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20608.Liking for baked or steamed fish,36661,0.00376131768308361,0.0201245878054097,-0.0356828744155195,0.0432055097816867,0.85174249257924
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20609.Liking for bananas,36661,0.0282786743167447,0.0205366516709948,-0.0119731629584051,0.0685305115918946,0.168554969686879
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36661,-0.0153794067186786,0.0201671279311358,-0.0549069774637048,0.0241481640263475,0.445725655883957
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20611.Liking for beef steak,36661,0.00782293665916776,0.0203148179374787,-0.0319941064982905,0.0476399798166261,0.700184430141752
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20612.Liking for beetroot,36661,0.0169579324490817,0.0201251781051907,-0.0224874166370921,0.0564032815352556,0.399464504137242
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20613.Liking for bell pepper,36661,-0.00649199710490756,0.0200282683259392,-0.0457474030237484,0.0327634088139333,0.745839170927958
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20614.Liking for bicycling,36661,0.00524269097937309,0.0200095981216695,-0.0339761213390991,0.0444615032978453,0.793321352640607
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20615.Liking for biscuits,36661,0.0290884547410221,0.0201254259262864,-0.0103573800744993,0.0685342895565434,0.148396139801572
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20616.Liking for bitter foods,36661,-0.0256484423343197,0.0199589647115995,-0.0647680131690548,0.0134711285004154,0.198808715992518
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20617.Liking for bitter or ale,36661,-0.0198945508716454,0.0200954809016906,-0.0592816934389589,0.0194925916956681,0.322203264461587
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20618.Liking for black olives,36661,-0.0325792833256412,0.0199710619307315,-0.071722564709875,0.00656399805859256,0.102860966443522
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20619.Liking for black pepper,36661,-0.0266103333872043,0.0202257222284359,-0.0662527489549387,0.0130320821805301,0.188322992839115
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20620.Liking for blue cheese,36661,0.00736124636838534,0.0199786633435084,-0.0317969337848912,0.0465194265216619,0.712543382432873
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20621.Liking for bolognese sauce,36661,-0.00649631097384285,0.0201103099657104,-0.0459125185066353,0.0329198965589496,0.746677990140489
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20622.Liking for broad beans,36661,-0.0143711059504942,0.0200175407255538,-0.0536054857725796,0.0248632738715913,0.472823959386695
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20623.Liking for broccoli,36661,0.0231493536888799,0.0200986794519456,-0.0162440580369334,0.0625427654146932,0.249443708380618
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20624.Liking for brown rice,36661,-0.00469507131536949,0.0199739340329317,-0.0438439820199156,0.0344538393891766,0.814168204494293
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20625.Liking for brussel sprouts,36661,0.00092181984069096,0.0201245605371811,-0.038522318812184,0.040365958493566,0.963466241326213
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20626.Liking for burgers (meat),36661,-0.014114657033863,0.0199167414634994,-0.0531514703023219,0.024922156234596,0.478541703481425
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20627.Liking for burn of spicy foods,36661,-0.025139606678148,0.0200498547799241,-0.0644373220467993,0.0141581086905032,0.209931187482115
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20628.Liking for butter on bread,36661,0.0157881520190876,0.0202212094258711,-0.0238454184556197,0.055421722493795,0.434959619067547
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20629.Liking for butternut squash,36661,-0.0424812831446559,0.0199039943332992,-0.0814931120379224,-0.00346945425138941,0.0328475759594128
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20630.Liking for cabbage,36661,0.0043877378234757,0.0201301022713189,-0.0350672626283094,0.0438427382752608,0.827458805478788
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20631.Liking for cake,36661,0.0260829298063107,0.0200860478908393,-0.0132857240597343,0.0654515836723558,0.194132307061662
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20632.Liking for cake icing,36661,0.0198601596693638,0.0198192934172295,-0.018985655428406,0.0587059747671337,0.316343788945041
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20633.Liking for capers,36661,-0.022309588284517,0.0199848174954504,-0.0614798305755997,0.0168606540065657,0.264315565648834
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20634.Liking for cauliflower,36661,0.00884198075804454,0.0201805137335135,-0.030711826159642,0.048395787675731,0.661293303549797
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20635.Liking for cereal or granola bar,36661,0.00762720722318698,0.0198959412187208,-0.0313688375655058,0.0466232520118798,0.701466734033185
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20636.Liking for cheesecake,36661,0.0220533143891719,0.0199734329630989,-0.0170946142185019,0.0612012429968457,0.269568704249852
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20637.Liking for cherries,36661,0.00124198520939397,0.0203814658411234,-0.0387056878392078,0.0411896582579958,0.951410901623267
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20638.Liking for chicken,36661,0.00999142247821734,0.0207363348708925,-0.0306517938687319,0.0506346388251666,0.629938638082156
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20639.Liking for chilli pepper,36661,-0.0138595441777977,0.0200185999018946,-0.0530959999855111,0.0253769116299157,0.488747980526346
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20640.Liking for chips or french fries,36661,0.0138265844385558,0.020261791564527,-0.0258865270279172,0.0535396959050288,0.495007624014941
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20641.Liking for cigarette smoking,36661,-0.0104075017887139,0.0312721930824105,-0.0717010002302385,0.0508859966528107,0.739291123852526
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20642.Liking for cod,36661,0.0451687947228825,0.020575099018143,0.00484160064732223,0.0854959887984428,0.0281695471723061
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20643.Liking for coffee with sugar,36661,-0.0218474909269262,0.0208762216443258,-0.0627648853498047,0.0190699034959523,0.29535005445623
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20644.Liking for coffee without sugar,36661,0.00582959625769647,0.0201954323610861,-0.0337534511700323,0.0454126436854252,0.772849659692684
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20645.Liking for coriander,36661,-0.0156560094896524,0.0199615153214235,-0.0547805795196423,0.0234685605403376,0.432881498987954
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20646.Liking for corn flakes,36661,0.0303500582101519,0.0199647199804193,-0.0087807929514698,0.0694809093717737,0.128503871785325
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20647.Liking for cream,36661,0.024635604903918,0.0199877200199007,-0.0145403263350874,0.0638115361429233,0.217784532266875
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20648.Liking for croissant,36661,-0.00974841159381868,0.0200403330198117,-0.0490274643126496,0.0295306411250123,0.626668757957195
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20649.Liking for cucumber,36661,-0.00492359766432844,0.0199899212336614,-0.0441038432823048,0.0342566479536479,0.805453188057235
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20650.Liking for curry,36661,0.0049265054629334,0.0203183046469574,-0.0348973716451031,0.0447503825709699,0.808424991897648
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20651.Liking for dairy products,36661,0.0199647054885407,0.020263655417448,-0.0197520591296574,0.0596814701067388,0.32453236821173
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20652.Liking for dark chocolate,36661,-0.0167725178528724,0.0200744492692811,-0.0561184384206634,0.0225734027149186,0.403452192847595
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20653.Liking for diet fizzy drinks,36661,0.0035518961086128,0.0203431336292903,-0.0363206458047963,0.0434244380220219,0.861398918584712
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20654.Liking for dried fruit,36661,-0.0207415565084523,0.0200816534201594,-0.0601015972119648,0.0186184841950601,0.301699975655665
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20655.Liking for eggs,36661,0.0116565485364178,0.0205521954225813,-0.0286257544918415,0.0519388515646772,0.570615825739589
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20656.Liking for exercising alone,36661,0.0121032342778094,0.0199556460830146,-0.0270098320448991,0.051216300600518,0.544195392572199
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20657.Liking for exercising with others,36661,0.0194397608444325,0.0198382182073961,-0.0194431468420638,0.0583226685309289,0.327157686615853
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20658.Liking for extra virgin olive oil,36661,2.75031919732267e-05,0.0201835911151602,-0.0395323353937407,0.0395873417776871,0.998912795844461
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20659.Liking for fatty foods,36661,-0.0292259682847356,0.0199066721424754,-0.0682430456839873,0.00979110911451618,0.142102713066163
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20660.Liking for fresh tomatoes,36661,-0.0190052001433641,0.0206640276612247,-0.0595066943593644,0.0214962940726362,0.357744610449514
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20661.Liking for fried chicken,36661,-0.0142096843855005,0.0200162871553623,-0.0534416072100106,0.0250222384390096,0.477782923863378
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20662.Liking for fried or battered fish,36661,0.016379688449226,0.0200679879275228,-0.0229535678887187,0.0557129447871706,0.414404296875345
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20663.Liking for fruit,36661,0.00819461613802777,0.0210999677904514,-0.0331613207312571,0.0495505530073126,0.697751750453505
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20664.Liking for garlic,36661,-0.0109517398932092,0.0201887590004657,-0.0505217075341221,0.0286182277477036,0.587511698937903
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20665.Liking for gherkins,36661,-0.021619502608572,0.0198910423119417,-0.0606059455399777,0.0173669403228336,0.277115125078018
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20666.Liking for globe artichoke,36661,-0.0158000907213685,0.0200805772150247,-0.055158022062817,0.0235578406200799,0.431401918022567
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20667.Liking for goat's cheese,36661,-0.00378301481271043,0.0198539727781881,-0.0426968014579591,0.0351307718325383,0.848889272589327
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20668.Liking for going to a cafe,36661,-0.0106877845366838,0.0200539928751559,-0.0499936105719894,0.0286180414986217,0.594082588482543
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20669.Liking for going to the gym,36661,0.00602656984983943,0.0198954920669203,-0.0329685946013244,0.0450217343010032,0.761965266026866
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20670.Liking for going to the pub,36661,0.01180366528063,0.0199458283140142,-0.027290158214838,0.0508974887760979,0.5540104020221
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20671.Liking for grapefruit,36661,0.0329079473862086,0.0200178106650303,-0.00632696151725085,0.0721428562896679,0.100229001624312
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20672.Liking for green olives,36661,-0.0203888378871024,0.0199527259556619,-0.0594961807601997,0.0187185049859949,0.306879162863148
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20673.Liking for haddock,36661,-0.00847384896266551,0.0204612062395292,-0.0485778131921427,0.0316301152668117,0.678781000276448
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20674.Liking for ham,36661,0.0347699602997783,0.0203399383244215,-0.00509631881608791,0.0746362394156445,0.0874074972363225
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20675.Liking for hard cheese,36661,0.00928197930540741,0.020392676610972,-0.0306876668520977,0.0492516254629125,0.6490046920854
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20676.Liking for herring,36661,-0.020352870903105,0.0198804489442776,-0.0593185508338891,0.0186128090276792,0.305977918133359
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20677.Liking for honey,36661,0.00519840068029504,0.01997458625676,-0.0339517883829546,0.0443485897435446,0.794677028632659
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20678.Liking for horseradish or wasabi,36661,-0.0162336296565735,0.0200077421687721,-0.0554488043073669,0.0229815449942199,0.417178699792339
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20679.Liking for ice cream,36661,0.0368133722196682,0.0202087859445165,-0.00279584823158411,0.0764225926709206,0.0685449129742943
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20680.Liking for jam,36661,0.031824384149666,0.0201094653826173,-0.00759016800026385,0.0712389362995959,0.113561643854992
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20681.Liking for kiwi fruit,36661,0.00066366634416022,0.0199542362401466,-0.0384466366865271,0.0397739693748476,0.97346853755521
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20682.Liking for lager,36661,-0.0280254210453386,0.0199134397048005,-0.0670557628667475,0.0110049207760704,0.159358632708124
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20683.Liking for lamb,36661,0.0107889021534862,0.020289663990274,-0.0289788392674508,0.0505566435744233,0.594918150998712
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20684.Liking for lemons,36661,-0.00497810393885223,0.020079025546905,-0.0443329940107861,0.0343767861330817,0.804198314072757
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20685.Liking for lentils or beans,36661,-0.0239865929462692,0.0201769719242068,-0.0635334579177145,0.0155602720251761,0.234549364853811
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20686.Liking for liver,36661,0.0383633668638553,0.0199414542500435,-0.000721883466230047,0.0774486171939406,0.0544148863505253
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20687.Liking for mackerel,36661,0.0133252620747351,0.0200328238144665,-0.0259390726016192,0.0525895967510894,0.505959902700704
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20688.Liking for marzipan,36661,0.00535161778328243,0.0198206767850097,-0.0334969087153365,0.0442001442819014,0.787165812460165
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20689.Liking for mayonnaise,36661,-0.0253521454067647,0.0200949488786992,-0.0647382452090152,0.0140339543954857,0.207122890392123
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20690.Liking for melon,36661,-0.00209621984525061,0.0202722177092313,-0.0418297665553439,0.0376373268648427,0.917645247681141
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20691.Liking for milk chocolate,36661,0.0312766590353163,0.0201301011605348,-0.00817833923933198,0.0707316573099646,0.120289119570628
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20692.Liking for mushrooms,36661,0.00432489572949704,0.020469903647026,-0.0357961154186739,0.044445906877668,0.832673583045473
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20694.Liking for orange juice,36661,0.00677258222371744,0.020079435485723,-0.0325831113282995,0.0461282757757344,0.735907485649586
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20695.Liking for oranges,36661,0.0269164723790989,0.0203703827837581,-0.013009477877067,0.0668424226352648,0.186421136171101
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20696.Liking for pasta,36661,0.0150969656757825,0.0202555331071352,-0.0246038792142025,0.0547978105657676,0.456096714101114
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20697.Liking for pears,36661,-0.0023829146895546,0.0202709339464782,-0.0421139452246519,0.0373481158455427,0.906424560640251
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20698.Liking for pizza,36661,-0.0159092563290187,0.0200114257832946,-0.055131650864276,0.0233131382062387,0.426631910932017
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20699.Liking for plain yogurt,36661,0.00626464858933415,0.0198486401044075,-0.0326386860153045,0.0451679831939728,0.752298339647854
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20700.Liking for plums,36661,-0.0195910857690875,0.0202704243350516,-0.0593211174657886,0.0201389459276136,0.333829966487911
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20701.Liking for pollock,36661,0.0191622163036921,0.020008372035509,-0.0200541928859056,0.0583786254932898,0.338237809042813
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20702.Liking for pork chop,36661,0.00354584132413182,0.0200200536465999,-0.035693463823204,0.0427851464714677,0.859422925748501
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20703.Liking for porridge,36661,0.0208473611955468,0.0200621648049712,-0.0184744818221967,0.0601692042132903,0.298771683714742
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20704.Liking for potato crisps,36661,0.0118694375571093,0.020105827650277,-0.0275379846374337,0.0512768597516522,0.55497385184621
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20705.Liking for potatoes,36661,0.0333657957274964,0.0203916396025124,-0.00660181789342791,0.0733334093484208,0.101826605372472
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20706.Liking for prawns,36661,0.0267313704715675,0.0201938469470986,-0.0128485695447457,0.0663113104878807,0.185627523246045
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20707.Liking for raw carrots,36661,-0.00200629244991906,0.019920726089912,-0.0410509155861465,0.0370383306863084,0.919780146748676
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20708.Liking for red meat,36661,-0.00741616576052133,0.0202472106863233,-0.0471006987057151,0.0322683671846724,0.714165132906115
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20709.Liking for red wine,36661,-0.0201942209137482,0.0202068486563482,-0.0597996442801906,0.0194112024526942,0.317643060227229
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36661,0.0190985866223202,0.0202468524511214,-0.0205852441818776,0.0587824174265181,0.345562578409775
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20711.Liking for roast chicken,36661,0.0206497665940985,0.0206766665261033,-0.019876499797064,0.0611760329852609,0.317970526569254
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20712.Liking for salad dressing,36661,-0.0100183293636237,0.0200991046879998,-0.0494125745521033,0.0293759158248559,0.618182949284533
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20713.Liking for salad leaves,36661,-0.0198201022659572,0.0200893081596123,-0.0591951462587972,0.0195549417268829,0.323868638711351
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20714.Liking for salami,36661,-0.024832204566783,0.0200499912164523,-0.0641301873510295,0.0144657782174635,0.215561459307576
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20715.Liking for salmon,36661,-0.0193125500916879,0.0204084561221306,-0.0593131240910638,0.0206880239076881,0.344023288470001
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20716.Liking for salty foods,36661,-0.0101925868902875,0.0199052716678454,-0.0492069193592645,0.0288217455786895,0.608626806780864
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20717.Liking for salty pretzels,36661,-0.0111271510148389,0.0199266652638519,-0.0501834149319887,0.0279291129023108,0.576583334713592
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20718.Liking for sardines,36661,0.00220251729038564,0.0199737590389566,-0.0369460504259694,0.0413510850067407,0.912197564777024
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20719.Liking for sausages (meat),36661,-0.0022733705771173,0.0200974875184635,-0.0416644461133058,0.0371177049590712,0.909940495836239
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20720.Liking for savoury biscuits,36661,0.00221688411541974,0.020206009739811,-0.0373868949746098,0.0418206632054493,0.912638854111838
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36661,0.00795813776601105,0.0199346909525552,-0.0311138565009972,0.0470301320330193,0.689748700934319
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20722.Liking for skimmed milk,36661,0.00865497407687129,0.0200110416147796,-0.0305666674880966,0.0478766156418392,0.665382424348956
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20723.Liking for smoked fish,36661,-0.00670830700725341,0.0200160919182534,-0.04593984716703,0.0325232331525232,0.737523916128968
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20724.Liking for soft cheese,36661,0.0158725541340543,0.019966665018252,-0.0232621093017196,0.0550072175698281,0.426664451626632
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20725.Liking for soy sauce,36661,-0.0229552078293926,0.0200166015603928,-0.0621877468877624,0.0162773312289772,0.251494871815303
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20726.Liking for soya milk,36661,-0.011478065301861,0.0201528824219506,-0.0509777148488841,0.0280215842451621,0.568999136273959
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20727.Liking for spicy foods,36661,0.0126062859743522,0.0201122222487193,-0.0268136696331376,0.0520262415818419,0.530809904358409
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20728.Liking for spinach,36661,-0.0074683072306001,0.0199736571095217,-0.0466166751652626,0.0316800607040624,0.70848271906161
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20729.Liking for spirits,36661,0.0145624949448406,0.019961696984155,-0.0245624311441032,0.0536874210337844,0.465703702034599
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20730.Liking for strawberries,36661,0.0264769346079736,0.0207712991358383,-0.0142348116982695,0.0671886809142167,0.202456327315347
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36661,-0.00415869569347032,0.0202135942000799,-0.0437773403256269,0.0354599489386863,0.837001113037707
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20732.Liking for sweet foods,36661,0.0274997024884661,0.0198677585043263,-0.0114411041800135,0.0664405091569457,0.166354826454821
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20733.Liking for taking the stairs,36661,0.0194598978642759,0.0203606995643157,-0.0204470732817829,0.0593668690103346,0.339223295157327
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20734.Liking for tea with sugar,36661,-0.0106941057906894,0.0220532125767002,-0.0539184024410218,0.032530190859643,0.627744293710484
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20735.Liking for tea without sugar,36661,0.0103703675567423,0.0204902604949834,-0.0297905430134252,0.0505312781269098,0.612791854099381
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20736.Liking for tomato ketchup,36661,0.0375425173733549,0.0199659475180195,-0.00159073976196336,0.0766757745086732,0.0600995435369667
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20737.Liking for tinned tuna,36661,-0.0118819437905082,0.0200078288078896,-0.0510972882539718,0.0273334006729554,0.552619275455438
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20738.Liking for turnip (white),36661,-0.0095361555923429,0.0200349847393785,-0.0488047256815247,0.029732414496839,0.634104969464593
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20739.Liking for vegetables,36661,0.0173149524601506,0.0206683087894562,-0.0231949327671836,0.0578248376874848,0.40219390439864
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20740.Liking for vinegar,36661,0.00108709015362725,0.0199853152979124,-0.0380841278302811,0.0402583081375356,0.956622253235706
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20741.Liking for watching television,36661,-0.00377571657440915,0.0201511250554164,-0.0432719216830253,0.035720488534207,0.851375252923143
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20742.Liking for whisky,36661,0.00663396298312883,0.0200228564950331,-0.032610835747136,0.0458787617133937,0.740411778747501
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20743.Liking for white bread,36661,0.00680177883249605,0.0199161650807313,-0.0322339047257373,0.0458374623907294,0.732720680031364
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20744.Liking for white rice,36661,0.0120261849010648,0.0202329957731858,-0.0276304868143794,0.051682856616509,0.552271480339594
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20745.Liking for white wine,36661,0.00201357775019025,0.0198677506006952,-0.0369272134271723,0.0409543689275529,0.9192758997626
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36661,0.0181231852263999,0.0201991607686328,-0.0214671698801203,0.0577135403329201,0.369625871993475
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20747.Liking for whole milk,36661,0.0369845417172921,0.0198537869172355,-0.00192888064048955,0.0758979640750738,0.0625203643971784
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20748.Liking for wholemeal bread,36661,0.00132165485895321,0.0205218224356596,-0.0389011171149396,0.041544426832846,0.948651408399862
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20749.Liking for working up a sweat,36661,0.00732270039685342,0.0201331839506048,-0.0321383401463319,0.0467837409400388,0.716081896234125
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X21001.Body mass index (BMI),52255,0.053909175535732,0.0340835368886197,-0.0128945567659625,0.120712907837427,0.113736499948761
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X21002.Weight,52287,-0.0780641130485055,0.0165004334722927,-0.110404962654199,-0.0457232634428119,2.24666858940611e-06
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X21021.Pulse wave Arterial Stiffness index,36538,0.019942900376111,0.0120882652367363,-0.00375009948789217,0.0436359002401143,0.0990288237547224
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,36419,-0.0389690306561822,0.0220126285910143,-0.0821137826945703,0.00417572138220584,0.0767156008043871
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,36421,-0.0222292420173674,0.0224378959886092,-0.0662075181550414,0.0217490341203067,0.321862349558399
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,36422,0.016857683314889,0.0216842815256007,-0.0256435084752883,0.0593588751050664,0.436937550968929
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21040.Satisfaction with bowel habits,36396,-0.016047913164866,0.0201388387881676,-0.0555200371896744,0.0234242108599424,0.425554386525846
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,36394,-0.0282346960098979,0.0219977928103619,-0.0713503699182072,0.0148809778984114,0.199346744271806
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21042.Greatest number of times bowels opened per day,36390,0.0071394281113575,0.021854828487482,-0.0356960357241072,0.0499748919468222,0.743922418574478
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21043.Least number of times bowels opened per week,36358,-0.0012685210210551,0.0219431260437164,-0.0442770480667393,0.0417400060246291,0.953901864454664
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21044.Average number of times bowels opened per day,36366,0.0214023906608438,0.0238966308458564,-0.0254350057970347,0.0682397871187222,0.370481522387716
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,36428,-0.0106480058330628,0.0219246044607652,-0.0536202305761625,0.0323242189100369,0.627218529991568
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,36424,-0.0057811368674656,0.0219258496929363,-0.0487558022656207,0.0371935285306895,0.792042983714576
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,36426,-0.010058455714345,0.0253594291192951,-0.0597629367881633,0.0396460253594734,0.691646915650791
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,36426,0.0202567143517183,0.0319815569578013,-0.0424271372855723,0.082940565989009,0.526499219796376
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,36426,0.0548748120427709,0.0268532392247273,0.00224246316230542,0.107507160923236,0.0410355853587938
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,36424,0.0900190375144592,0.0649387837114412,-0.0372609785599655,0.217299053588884,0.165721138843627
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,36428,0.0432810059166011,0.0272539847278918,-0.0101368041500668,0.0966988159832689,0.112312807924846
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,36426,0.0363503598246327,0.0250093359103241,-0.0126679385596026,0.0853686582088679,0.146132957884944
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,36283,-0.00544408171692517,0.0249168112085886,-0.0542810316857588,0.0433928682519085,0.827052914830931
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,36422,0.00526217737059639,0.0225250557675536,-0.0388869319338087,0.0494112866750015,0.815290462241661
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,36427,0.0336714123508354,0.0383265221418199,-0.0414485710471316,0.108791395748802,0.379677293485043
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,36428,-0.00450439229305001,0.0220259358001145,-0.0476752264612745,0.0386664418751745,0.837964972514634
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,36427,-0.0245980308240244,0.0220000569710054,-0.0677181424871949,0.0185220808391462,0.263563126858054
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X21100.Water hardness (USGS classification),52117,0.0406746100599485,0.0124699815241699,0.0162334462725754,0.0651157738473215,0.00110864147069053
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2139.Age first had sexual intercourse,49275,-0.0126486116779501,0.00676596913608714,-0.0259099111846809,0.000612687828780687,0.0615749607385585
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2149.Lifetime number of sexual partners,47593,0.00811829315142707,0.0141628892075468,-0.0196409696953646,0.0358775559982187,0.566510093077668
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22032.IPAQ activity group,48469,-0.00329379499172967,0.0135170591879381,-0.0297872310000884,0.0231996410166291,0.80748358625683
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22033.Summed days activity,48877,0.00373206567495114,0.00671440657733551,-0.00942817121662646,0.0168923025665287,0.57833350624286
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22034.Summed minutes activity,48469,0.000907007064405762,0.00679250429652463,-0.0124063013567825,0.014220315485594,0.893775130777569
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22037.MET minutes per week for walking,47750,-0.00241963359880198,0.00694196040112513,-0.0160258759850072,0.0111866087874033,0.727429563463107
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22038.MET minutes per week for moderate activity,48469,0.00843029165009436,0.00689149877539322,-0.00507704594967635,0.0219376292498651,0.221235232249286
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22039.MET minutes per week for vigorous activity,48469,-0.0164001483132861,0.0134449281194599,-0.0427522074274274,0.00995191080085529,0.222554475863112
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22040.Summed MET minutes per week for all activity,47750,0.000900489164280127,0.00688411002170894,-0.0125923664782694,0.0143933448068297,0.895929430107417
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X2217.Age started wearing glasses or contact lenses,48554,-0.000366120577234661,0.0070128986567693,-0.0141114019445025,0.0133791607900332,0.958364485062623
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X22501.Year ended full time education,34204,-0.0329292956281916,0.031455086007582,-0.0945812642030523,0.028722672946669,0.295206012982384
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X22506.Tobacco smoking,34166,0.0955234048674742,0.0488995077418554,-0.000319630306562388,0.191366440041511,0.0508147419223694
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50906,-0.000351393112334928,0.0382048581516644,-0.0752329150895972,0.0745301288649274,0.992661560411627
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23098.Weight,51840,-0.0745898268198497,0.0166881411556287,-0.107298583484882,-0.0418810701548174,7.87249384575545e-06
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23099.Body fat percentage,51810,0.0858802243171847,0.0148736613726403,0.0567278480268096,0.11503260060756,7.84077223223487e-09
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23100.Whole body fat mass,51766,0.0444124405278139,0.0148759822739535,0.015255515270865,0.0735693657847627,0.00283398702173236
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23101.Whole body fat-free mass,51834,-0.0929370392112071,0.014417578503116,-0.121195493077314,-0.0646785853450998,1.17023939502124e-10
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23102.Whole body water mass,51840,-0.0953536476467971,0.0143786501885271,-0.12353580201631,-0.067171493277284,3.39326806816616e-11
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23104.Body mass index (BMI),51840,0.0546659128789164,0.033794800844582,-0.0115718967764643,0.120903722534297,0.105765954588935
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23105.Basal metabolic rate,51840,-0.0968205144560857,0.0149760470402427,-0.126173566654961,-0.06746746225721,1.03293095589203e-10
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23106.Impedance of whole body,51840,0.0619406079768062,0.0117916217779876,0.0388290292919506,0.0850521866616618,1.51013852059271e-07
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23107.Impedance of leg (right),51840,0.0634854872527973,0.00952380254075294,0.0448188342729215,0.082152140232673,2.68793942651033e-11
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23108.Impedance of leg (left),51840,0.0613190516245429,0.00949277167677903,0.042713219138056,0.0799248841110298,1.07091418323017e-10
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23109.Impedance of arm (right),51840,0.0264844510725129,0.0116820604156796,0.00358761265778095,0.0493812894872449,0.0233929917071033
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23110.Impedance of arm (left),51840,0.0251287975387441,0.0116705058586417,0.00225460605580629,0.0480029890216819,0.031314133215275
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23111.Leg fat percentage (right),51840,0.103819955360088,0.0151454848261838,0.0741348051007675,0.133505105619408,7.31765174938541e-12
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23112.Leg fat mass (right),51840,0.074833202094079,0.0163326511527765,0.0428212058346372,0.106845198353521,4.63350163983588e-06
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23113.Leg fat-free mass (right),51839,-0.111978419124952,0.0158377296330326,-0.143020369205696,-0.080936469044208,1.58908303336582e-12
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23114.Leg predicted mass (right),51839,-0.113616019816142,0.0159546918836768,-0.144887215908148,-0.0823448237241352,1.10133763984696e-12
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23115.Leg fat percentage (left),51839,0.105269064409926,0.0158528919447517,0.0741973961982128,0.13634073262164,3.19802493551536e-11
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23116.Leg fat mass (left),51839,0.067745247781302,0.0172870014760582,0.033862724888228,0.101627770674376,8.92254801372304e-05
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23117.Leg fat-free mass (left),51838,-0.114886950424552,0.0172274901644494,-0.148652831146873,-0.0811210697022312,2.63664852562762e-11
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23118.Leg predicted mass (left),51838,-0.11647859656388,0.0173648576824834,-0.150513717621548,-0.0824434755062126,2.02230015366162e-11
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23119.Arm fat percentage (right),51838,0.0478140942853652,0.0167193572865204,0.0150441540037853,0.0805840345669452,0.00424279684576261
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23120.Arm fat mass (right),51837,-0.00848473396958095,0.0182610051008516,-0.0442763039672502,0.0273068360280883,0.642195967083994
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23121.Arm fat-free mass (right),51836,-0.0797012967084381,0.0158263618873349,-0.110720966007615,-0.0486816274092617,4.78957731014521e-07
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23122.Arm predicted mass (right),51836,-0.0773838768310648,0.0158996060695789,-0.108547104727439,-0.0462206489346902,1.14029926746742e-06
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23123.Arm fat percentage (left),51834,0.0427681329518341,0.0157420301020543,0.0119137539518078,0.0736225119518605,0.00659628777601689
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23124.Arm fat mass (left),51834,-0.0148511900176204,0.017547323384661,-0.0492439438515561,0.0195415638163152,0.39736583024615
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23125.Arm fat-free mass (left),51830,-0.0703446541542489,0.0144117758955766,-0.098591734909579,-0.0420975733989189,1.06220116278533e-06
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23126.Arm predicted mass (left),51829,-0.0690538899424672,0.0144945103003328,-0.0974631301311194,-0.040644649753815,1.90805315920099e-06
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23127.Trunk fat percentage,51827,0.0623044585802041,0.0126017215558429,0.037605084330752,0.0870038328296563,7.70205227902602e-07
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23128.Trunk fat mass,51827,0.0336840304811172,0.0132843069608894,0.00764678883777391,0.0597212721244605,0.0112311618591893
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23129.Trunk fat-free mass,51826,-0.0740079221830972,0.0124983752985946,-0.0985047377683427,-0.0495111065978517,3.2369485865659e-09
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23130.Trunk predicted mass,51824,-0.0756431250004155,0.0124895270038786,-0.100122597928017,-0.0511636520728135,1.41231399955417e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23400.Total Cholesterol,42185,0.0688185597345606,0.00885611112535159,0.0514605819288715,0.0861765375402497,8.36100338097109e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,42185,0.0752033882215351,0.00864659833328725,0.0582560554882921,0.0921507209547781,3.78001054342775e-18
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",42185,0.0760676532707485,0.00869748993587945,0.0590205729964248,0.0931147335450723,2.46916510466434e-18
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23403.VLDL Cholesterol,42185,0.0902040205021297,0.00895992882118182,0.0726425600126133,0.107765480991646,9.31762050898645e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23404.Clinical LDL Cholesterol,42185,0.0611960469055765,0.00863357903946567,0.0442742319882238,0.0781178618229292,1.4263044979369e-12
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23405.LDL Cholesterol,42185,0.0716318036864574,0.00858905243670189,0.0547972609105217,0.0884663464623931,8.14610385717937e-17
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23406.HDL Cholesterol,42185,-0.00223852666123961,0.00981714621650477,-0.021480133245589,0.0170030799231097,0.819632462589646
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23407.Total Triglycerides,42185,0.10689772116944,0.00910180690897822,0.089058179627843,0.124737262711038,1.07037314200758e-31
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23408.Triglycerides in VLDL,42185,0.102096276184008,0.00924411279334875,0.0839778151090444,0.120214737258971,3.07457568481534e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23409.Triglycerides in LDL,42185,0.117685371782878,0.00855443277548929,0.100918683542919,0.134452060022837,8.91561909844052e-43
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23410.Triglycerides in HDL,42185,0.10623030324658,0.00890116447555794,0.0887840208744868,0.123676585618674,1.14025768060495e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,42185,0.0902201137782098,0.00889076140634865,0.0727942214217665,0.107646006134653,4.13832793856647e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23412.Phospholipids in VLDL,42185,0.102496066195698,0.00904812230520477,0.0847617464774962,0.120230385913899,1.29642843600478e-29
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23413.Phospholipids in LDL,42185,0.0733396018871767,0.00861586329664984,0.056452509825743,0.0902266939486104,1.8847415935181e-17
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23414.Phospholipids in HDL,42185,0.036671011144079,0.00940251433729285,0.018242083042985,0.055099939245173,9.66045908503443e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23415.Total Esterified Cholesterol,42185,0.0668041654846719,0.00890464583997572,0.0493510596383195,0.0842572713310243,6.66637845174343e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,42185,0.0813951410663115,0.00891573598727751,0.0639202985312475,0.0988699836013754,7.8484855055458e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,42185,0.0783227943240112,0.00858387008560903,0.0614984089562175,0.0951471796918049,8.21437436488389e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,42185,-0.0107178604849063,0.00982333965106288,-0.0299716062009895,0.00853588523117695,0.275265495604664
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23419.Total Free Cholesterol,42185,0.0728124269255999,0.00874520117467742,0.0556718326232321,0.0899530212279676,9.15658046015735e-17
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23420.Free Cholesterol in VLDL,42185,0.0986143234466346,0.00901553719182209,0.0809438705506633,0.116284776342606,9.87091992076337e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23421.Free Cholesterol in LDL,42185,0.0512597369574508,0.00864236922056981,0.034320693285134,0.0681987806297676,3.0801232028063e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23422.Free Cholesterol in HDL,42185,0.02581916087188,0.00976286520965016,0.00668394506096573,0.0449543766827944,0.00818744596788671
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,42185,0.0956354771935214,0.00853709329614985,0.0789027743330677,0.112368180053975,5.32053347695153e-29
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23424.Total Lipids in VLDL,42185,0.10424158715655,0.00905806103782771,0.086487787522408,0.121995386790693,1.66193674910411e-30
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23425.Total Lipids in LDL,42185,0.077730652580532,0.00858590671962497,0.0609022754100671,0.0945590297509969,1.57379942491745e-19
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23426.Total Lipids in HDL,42185,0.0291454971328261,0.00955755248438854,0.0104126942634246,0.0478783000022276,0.00229684659052194
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,42185,0.0649255149194248,0.00906191398600163,0.0471641635068616,0.082686866331988,8.19987357411597e-13
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23428.Concentration of VLDL Particles,42185,0.0981051262945968,0.00893367988813362,0.0805951137138549,0.115615138875339,6.14803222223846e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23429.Concentration of LDL Particles,42185,0.0701085879665853,0.00863601837429466,0.0531819919529678,0.0870351839802029,5.13785796876185e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23430.Concentration of HDL Particles,42185,0.0556389053244947,0.00907331187288523,0.0378552140536397,0.0734225965953498,8.91026489027781e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,42185,0.081303563248441,0.0094045581141012,0.0628706293448027,0.0997364971520794,5.97063122534571e-18
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23432.Average Diameter for LDL Particles,42185,-0.0294585570656389,0.0089276393443673,-0.0469567301805988,-0.011960383950679,0.000970363815320178
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23433.Average Diameter for HDL Particles,42185,-0.0578501063795437,0.00982559239120405,-0.0771082674663036,-0.0385919452927838,4.00861310348732e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23434.Phosphoglycerides,42177,0.0897191903162586,0.00891330805569699,0.0722491065270925,0.107189274105425,9.48334066955155e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,42177,0.0818234115210933,0.00962020929146753,0.0629678013098169,0.10067902173237,1.99792653149696e-17
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23436.Total Cholines,42177,0.0875643563055268,0.00906578604287434,0.0697954156614931,0.105333296949561,5.31094850878512e-22
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23437.Phosphatidylcholines,42177,0.0733995424016984,0.0091118977610201,0.055540222790099,0.0912588620132977,8.5821202497488e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23438.Sphingomyelins,42177,0.0824386721908155,0.00914763348631153,0.0645093105576449,0.100368033823986,2.28984372164857e-19
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23439.Apolipoprotein B,42185,0.0726382767242357,0.00866481883739995,0.0556552318029318,0.0896213216455396,5.6570821936405e-17
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23440.Apolipoprotein A1,42185,0.0431833809826035,0.0093499451409259,0.0248574885063888,0.0615092734588183,3.89938924380328e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,42185,0.0433354066011632,0.00886132906152235,0.0259672016405793,0.060703611561747,1.01785080212504e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23442.Total Fatty Acids,42177,0.110827103071505,0.00830581811939849,0.0945476995574839,0.127106506585526,2.32622203675914e-40
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23443.Degree of Unsaturation,42177,-0.0738893169304628,0.00903213004365913,-0.0915922918160347,-0.0561863420448909,3.07077860576078e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23444.Omega-3 Fatty Acids,42177,0.0247488518806459,0.00878499852695131,0.00753025476782138,0.0419674489934705,0.00485185283851696
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23445.Omega-6 Fatty Acids,42177,0.0885274018244904,0.00861241106554435,0.0716470761360234,0.105407727512957,1.07877264941518e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,42177,0.0815304546777278,0.008658714990277,0.0645593732967848,0.0985015360586707,5.4300110343073e-21
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,42177,0.119406842904564,0.00845544118084659,0.102834178190105,0.135979507619024,5.79170824593752e-45
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23448.Saturated Fatty Acids,42177,0.112950171370432,0.00819370611021757,0.0968905073944056,0.129009835346458,6.10613682198488e-43
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23449.Linoleic Acid,42177,0.0840318350549013,0.00860115340587377,0.0671735743793887,0.100890095730414,1.79895618931161e-22
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23450.Docosahexaenoic Acid,42177,-0.00930419665676467,0.0087215115055179,-0.0263983592075798,0.00778996589405041,0.28607656104686
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,42177,-0.0396184428190663,0.00880734527542109,-0.0568808395588916,-0.022356046079241,6.90540546539509e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,42177,-0.092845917918689,0.00862511369059752,-0.10975114075226,-0.0759406950851178,6.49505418029859e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,42177,-0.112316576341787,0.00881147691041306,-0.129587071086196,-0.0950460815973769,5.30422102982632e-37
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,42177,0.105963131319885,0.00926267964938586,0.0878082792070886,0.124117983432681,3.63594063803361e-30
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,42177,0.0702212917491123,0.00804691417521828,0.0544493399656845,0.0859932435325401,2.93007233542078e-18
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,42177,-0.0476062307656814,0.00886413089375555,-0.0649799273174422,-0.0302325342139205,7.97418742041216e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,42177,-0.0748189095778633,0.00861276626537187,-0.0916999314579922,-0.0579378876977344,4.14338356772995e-18
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,42177,-0.115414283953915,0.00916460206490193,-0.133376904001123,-0.0974516639067072,3.65211293936232e-36
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,42177,0.00900460239205352,0.00870376312518772,-0.00805477333331441,0.0260639781174215,0.300890871549531
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23460.Alanine,42182,0.0736635351737823,0.008665943118175,0.0566782866621593,0.0906487836854053,2.08567664833176e-17
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23461.Glutamine,42144,-0.13319244977498,0.0084590325982603,-0.14977215366757,-0.116612745882389,2.27961585995187e-55
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23462.Glycine,42171,0.0777948803704135,0.010326447656522,0.0575550429636305,0.0980347177771966,5.24949873956327e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23463.Histidine,42169,0.0301220562931949,0.00859958418735233,0.0132668712859844,0.0469772413004055,0.000461990906555918
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),42174,0.0575314798178263,0.00964322990922541,0.0386307491957445,0.0764322104399081,2.49197016622726e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23465.Isoleucine,42183,0.0302303561855943,0.00930793405253524,0.0119868054426252,0.0484739069285634,0.00116581226142403
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23466.Leucine,42183,0.048638368741258,0.00956488362676687,0.0298911968327949,0.067385540649721,3.72329434074367e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23467.Valine,42174,0.0642771710808372,0.00957761316005925,0.0455050492871211,0.0830492928745533,2.00706492998122e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23468.Phenylalanine,42178,0.0251745876836239,0.00886784009446566,0.00779362109847123,0.0425555542687766,0.00453417245028612
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23469.Tyrosine,42172,0.0557420954774094,0.00916562168164508,0.0377774769813851,0.0737067139734338,1.22146867089368e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23470.Glucose,42164,-0.0434463783775914,0.00836590461082703,-0.0598435514148124,-0.0270492053403704,2.09625551991713e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23471.Lactate,42164,0.242518282871269,0.00853971627284433,0.225780438976494,0.259256126766044,2.19358403620444e-172
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23472.Pyruvate,42142,0.117652712262402,0.00838528962843738,0.101217544590665,0.134087879934139,2.06506439684173e-44
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23473.Citrate,42182,0.0457462306808206,0.00875202414800809,0.0285922633507247,0.0629001980109164,1.74900521280301e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23474.3-Hydroxybutyrate,41905,0.0912793880938286,0.0096455142445877,0.0723741801744367,0.11018459601322,3.47487972239232e-21
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23475.Acetate,42173,-0.131410853236391,0.00828242240277449,-0.147644401145829,-0.115177305326953,3.47060275867332e-56
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23476.Acetoacetate,42184,-0.00644873292436525,0.00877901643614272,-0.023655605139205,0.0107581392904745,0.462618894519042
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23477.Acetone,42184,-0.0410411100623164,0.00871853299927298,-0.0581294347408915,-0.0239527853837414,2.53447389623792e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23478.Creatinine,41925,0.0153051252017481,0.0105022930732604,-0.00527936922184237,0.0358896196253385,0.145053644386775
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23479.Albumin,42183,0.0684795867515813,0.00866419465464671,0.0514977652284737,0.0854614082746888,2.91399544786841e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23480.Glycoprotein Acetyls,42185,0.212844738154565,0.00884128890474497,0.195515811901265,0.230173664407865,1.95160975809554e-125
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,42185,0.0900562549644102,0.00917040440862111,0.0720822623235128,0.108030247605308,1.09537027164765e-22
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,42185,0.0853496332426931,0.00912127924559644,0.0674719259213241,0.103227340564062,9.45282972861882e-21
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,42185,0.0957789347902377,0.00941591028323145,0.0773237506351041,0.114234118945371,3.22798691235311e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,42185,0.0986219455561648,0.00925757387799176,0.0804771007553009,0.116766790357029,2.14347244466825e-26
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,42185,0.1004637843079,0.00925556267739175,0.0823228814602118,0.118604687155587,2.46000370794725e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,42185,0.0929809111897557,0.00919753169483001,0.0749537490678889,0.111008073311623,6.10377450355109e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,42185,0.0757257134345683,0.00895092561195775,0.0581818992351311,0.0932695276340055,2.94232056989366e-17
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,42185,0.106856488787601,0.00954121008511727,0.0881557170207707,0.12555726055443,5.49455305280665e-29
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,42185,0.104194281696533,0.00947519611774083,0.0856228973057613,0.122765666087305,5.21212216714362e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,42185,0.102142099201248,0.00947400632201823,0.0835730468100927,0.120711151592404,5.42505745137209e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,42185,0.102914547768533,0.00941127347755955,0.0844684517525162,0.12136064378455,1.0202451367227e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,42185,0.100913922009571,0.00939861619830991,0.0824926342608831,0.119335209758258,8.72786489160407e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,42185,0.100231183060334,0.00939321866845126,0.0818204744701691,0.118641891650498,1.7789091426606e-26
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,42185,0.101346570575215,0.00950436254444755,0.0827180199880974,0.119975121162332,1.92559987983102e-26
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,42185,0.104612803097052,0.00940233852480745,0.0861842195884295,0.123041386605675,1.24288735000922e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23496.Total Lipids in Large VLDL,42185,0.101949405798394,0.00937810812180587,0.0835683138796549,0.120330497717134,2.05474867491964e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23497.Phospholipids in Large VLDL,42185,0.106511955869661,0.00955769396191842,0.087778875704301,0.125245036035021,1.01905979446253e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23498.Cholesterol in Large VLDL,42185,0.103755245097463,0.00944340867231063,0.0852461640997339,0.122264326095192,5.7838356036607e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,42185,0.0954951289417218,0.00937900185144748,0.0771122853128847,0.113877972570559,2.92195486466405e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,42185,0.108737896012833,0.00952679338396003,0.0900653809802713,0.127410411045395,4.8837265258758e-30
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23501.Triglycerides in Large VLDL,42185,0.0949920780756904,0.00925419707062404,0.0768538518172673,0.113130304334114,1.24950370877527e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,42185,0.0863572898041071,0.0088604860414919,0.068990737162783,0.103723842445431,2.26398209718004e-22
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,42185,0.0941843573868839,0.00888217209699871,0.0767753000767664,0.111593414697001,3.6226609334236e-26
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,42185,0.0848368686888994,0.00883804238912883,0.0675143056062069,0.102159431771592,9.45742730046206e-22
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,42185,0.0532070602688032,0.00869697941982569,0.0361609806059449,0.0702531399316615,9.74339057958427e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,42185,0.0333616314558816,0.00867961105797681,0.0163495937822471,0.0503736691295162,0.000121756119651514
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,42185,0.0753407836885797,0.00879690609481434,0.0580988477427436,0.0925827196344158,1.20159268270398e-17
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,42185,0.102474656658887,0.00912553030749122,0.0845886172562045,0.12036069606157,3.92769061090036e-29
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,42185,0.100717316390936,0.00913969591203411,0.0828035124033494,0.118631120378523,4.03659310950031e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23510.Total Lipids in Small VLDL,42185,0.105655183636553,0.00914202838336796,0.0877368080051514,0.123573559267954,9.46545910999958e-31
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23511.Phospholipids in Small VLDL,42185,0.0926443352405554,0.00896705359162124,0.0750689102009778,0.110219760280133,6.26888235975295e-25
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23512.Cholesterol in Small VLDL,42185,0.0847391556679689,0.00904998056524732,0.0670011937600841,0.102477117575854,8.91216651164126e-21
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,42185,0.0893511501711449,0.00920942606620615,0.0713006750813809,0.107401625260909,3.48461173715766e-22
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,42185,0.0755119231184254,0.00880681462121271,0.0582505664608485,0.0927732797760023,1.10410984919149e-17
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23515.Triglycerides in Small VLDL,42185,0.105346725357523,0.00923108474347691,0.0872537992603086,0.123439651454738,4.98098281696465e-30
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,42185,0.0789673800772477,0.00875733809610642,0.0618029974088791,0.0961317627456163,2.18303175503836e-19
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,42185,0.0782610955605173,0.00882164519657893,0.0609706709752226,0.095551520145812,8.10884151823817e-19
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,42185,0.076089393361942,0.00879475210668027,0.0588516792328487,0.0933271074910353,5.63901684432998e-18
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,42185,0.0526139384264306,0.00888522210199823,0.035198903106514,0.0700289737463471,3.267006011877e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,42185,0.0454067018302725,0.00894895308781253,0.02786675377816,0.0629466498823851,3.94747788343839e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,42185,0.0675644178801675,0.00880633228961286,0.0503040065925262,0.0848248291678087,1.80480672583747e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,42185,0.103648613507411,0.00896155783890436,0.0860839601431589,0.121213266871664,8.54883205379837e-31
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23523.Concentration of IDL Particles,42185,0.0542347215905247,0.00868612120499117,0.037209924028742,0.0712595191523074,4.39676038950168e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23524.Total Lipids in IDL,42185,0.0603288025244049,0.00887167444373723,0.0429403206146799,0.0777172844341298,1.0887102103317e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23525.Phospholipids in IDL,42185,0.0565308418291608,0.00886812609713218,0.0391493146787818,0.0739123689795399,1.89357342709816e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23526.Cholesterol in IDL,42185,0.0501521098755363,0.00892055524244062,0.0326678216003526,0.0676363981507199,1.92383521289675e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,42185,0.0507815477907989,0.00893202846398487,0.0332747720013885,0.0682883235802092,1.33245445773891e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23528.Free Cholesterol in IDL,42185,0.0469261662577339,0.00885902636540035,0.0295624745815492,0.0642898579339186,1.19564913552175e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23529.Triglycerides in IDL,42185,0.105608321445195,0.00865388970028348,0.0886466976326397,0.122569945257751,4.48562877946711e-34
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23530.Concentration of Large LDL Particles,42185,0.0615997790266299,0.00860271540898369,0.0447384568250218,0.0784611012282379,8.45127051190558e-13
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23531.Total Lipids in Large LDL,42185,0.0715281941320479,0.00863115511879795,0.0546111300992039,0.0884452581648918,1.26728878470924e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23532.Phospholipids in Large LDL,42185,0.0678422042591799,0.0086591334782793,0.0508703026417525,0.0848141058766074,5.04502578596873e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23533.Cholesterol in Large LDL,42185,0.0649339415240172,0.00863977580936513,0.0479999809376616,0.0818679021103729,6.01455903553167e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,42185,0.0699960762207314,0.00862414793288506,0.0530927462722766,0.0868994061691861,5.21731274669869e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,42185,0.0497345768316836,0.00872015988261463,0.032643063461759,0.0668260902016083,1.19886626477837e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23536.Triglycerides in Large LDL,42185,0.116973145466012,0.00854113132070052,0.100232528077439,0.133713762854585,2.07199586092714e-42
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,42185,0.0798912810164734,0.00868669927379085,0.0628653504398433,0.0969172115931035,4.21080550792742e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23538.Total Lipids in Medium LDL,42185,0.0889724341972972,0.00862062005009494,0.0720760188991111,0.105868849495483,7.00595147562262e-25
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23539.Phospholipids in Medium LDL,42185,0.0861563641259723,0.00865442652521596,0.069193688136549,0.103119040115396,2.87606910582078e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23540.Cholesterol in Medium LDL,42185,0.0838012998257125,0.00861271146848919,0.0669203853474737,0.100682214303951,2.65697599897803e-22
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,42185,0.0910851103579702,0.00864154069720528,0.0741476905914479,0.108022530124493,7.08217471672826e-26
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,42185,0.0586646387696063,0.00858399943824785,0.0418399998706405,0.0754892776685721,8.59890326467059e-12
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23543.Triglycerides in Medium LDL,42185,0.118793388051842,0.00859924780400959,0.101938862355984,0.135647913747701,4.08249588989521e-43
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23544.Concentration of Small LDL Particles,42185,0.0776483907676807,0.00869610412648608,0.060604026679768,0.0946927548555934,4.83968899850806e-19
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23545.Total Lipids in Small LDL,42185,0.0783072301835855,0.0085676215562998,0.0615146919332379,0.0950997684339331,7.12538450973401e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23546.Phospholipids in Small LDL,42185,0.0603607752717989,0.00854725166719884,0.0436081620040892,0.0771133885395086,1.72090637275996e-12
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23547.Cholesterol in Small LDL,42185,0.0761646802339261,0.00859446475843494,0.0593195293073936,0.0930098311604586,8.82032632816708e-19
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,42185,0.0873577973869085,0.00859296399024809,0.0705155879660223,0.104200006807795,3.42554633678374e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,42185,0.0392576914997938,0.0086047846639931,0.0223923135583673,0.0561230694412203,5.10369344661576e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23550.Triglycerides in Small LDL,42185,0.110667293419341,0.00872184342838097,0.0935724802997143,0.127762106538968,1.10552291830727e-36
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,42185,-0.0353852968423774,0.0100154404773149,-0.0550155601779147,-0.0157550335068401,0.00041212024874685
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,42185,-0.0591054514220304,0.0100413260727662,-0.0787864505246521,-0.0394244523194087,4.04448719954998e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,42185,-0.0652230826849977,0.0099883382397378,-0.0848002256348837,-0.0456459397351116,6.81432238762221e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,42185,-0.0653389234717646,0.0101519155630168,-0.0852366779752776,-0.0454411689682516,1.26682786578174e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,42185,-0.0671412586202242,0.0102003312552502,-0.0871339078805146,-0.0471486093599338,4.8034962476203e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,42185,-0.0562285051885001,0.00988101172508165,-0.0755952881696602,-0.0368617222073401,1.29237399522191e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,42185,0.080138612129489,0.00835119798485598,0.0637702640791713,0.0965069601798067,9.73426778155953e-22
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23558.Concentration of Large HDL Particles,42185,-0.0460174865128526,0.010093433669034,-0.0658006165041592,-0.0262343565215459,5.18093543869038e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23559.Total Lipids in Large HDL,42185,-0.0420745730243944,0.0100085619455529,-0.061691354437678,-0.0224577916111108,2.64083075299371e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23560.Phospholipids in Large HDL,42185,-0.0309589223069231,0.00991534312933009,-0.0503929948404101,-0.0115248497734362,0.00179805507854732
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23561.Cholesterol in Large HDL,42185,-0.0659591006966978,0.0101481002685066,-0.0858493772229708,-0.0460688241704248,8.33173363372388e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,42185,-0.0727545737625927,0.0101795682793961,-0.0927065275902091,-0.0528026199349763,9.31399176225826e-13
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,42185,-0.0430390106101814,0.0100413896129151,-0.062720134251495,-0.0233578869688678,1.83040286755891e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23564.Triglycerides in Large HDL,42185,0.0720063282123313,0.0087925278040624,0.054772973716369,0.0892396827082936,2.85592497267756e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,42185,0.0375257231679633,0.00925115652793989,0.0193934563732012,0.0556579899627255,5.0128783793467e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23566.Total Lipids in Medium HDL,42185,0.0444679823238696,0.00909538446922,0.0266410287641984,0.0622949358835408,1.02471078191592e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23567.Phospholipids in Medium HDL,42185,0.0523270037712884,0.00893888857652644,0.0348067821612966,0.0698472253812802,4.91377908950579e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23568.Cholesterol in Medium HDL,42185,0.0195766882150337,0.00936010789353511,0.00123087674370493,0.0379224996863626,0.0365015750812765
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,42185,0.0144992885696601,0.00934786819599566,-0.00382253309449142,0.0328211102338116,0.120905880425703
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,42185,0.0390717640754296,0.0094002191871151,0.020647334468684,0.0574961936821752,3.2517841996698e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23571.Triglycerides in Medium HDL,42185,0.106357666010818,0.0089984410491652,0.0887207215544539,0.123994610467181,4.44103166384416e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23572.Concentration of Small HDL Particles,42185,0.0867341033980882,0.00863861607925953,0.0698024158827395,0.103665790913437,1.22575581109929e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23573.Total Lipids in Small HDL,42185,0.0999451618844609,0.00861993045288394,0.0830500981968084,0.116840225572113,6.13339620675611e-31
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23574.Phospholipids in Small HDL,42185,0.0969302411899566,0.00857649203841105,0.080120316794671,0.113740165585242,1.7395781052171e-29
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23575.Cholesterol in Small HDL,42185,0.076956451370134,0.00860243649238914,0.0600956758450513,0.0938172268952167,4.16139628610116e-19
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,42185,0.0658564157172547,0.00866110281525723,0.0488806541993505,0.0828321772351589,3.06636097407345e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,42185,0.0997415869700788,0.00855429592978459,0.082975166947701,0.116508006992457,2.88078758740521e-31
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23578.Triglycerides in Small HDL,42185,0.128555980792052,0.00967025568292659,0.109602279653516,0.147509681930589,4.46529241506565e-40
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41805,0.0380228675336979,0.00977960595932988,0.0188548398534113,0.0571908952139845,0.00010157862400085
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41805,-0.00583418827160002,0.00939821521822865,-0.0242546900993282,0.0125863135561281,0.534757602898428
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41805,0.00294277296274346,0.00951532826199194,-0.0157072704307607,0.0215928163562477,0.757123635702757
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41805,-0.0202347770086531,0.00938945318892584,-0.0386381052589478,-0.00183144875835847,0.0311756422398825
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41805,-0.00396160384493304,0.00951522031572697,-0.0226114356637579,0.0146882279738918,0.67716514676187
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,42111,0.0126092943120325,0.00958186409218605,-0.00617115930865217,0.0313897479327171,0.188211741402985
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,42111,-0.0522844252953532,0.00967443309335011,-0.0712463141583194,-0.033322536432387,6.61322413195525e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,42111,-0.049502753879242,0.00961666965849479,-0.0683514264098918,-0.0306540813485923,2.67546348254648e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,42111,-0.0474994470077271,0.00969539514242997,-0.0665024214868899,-0.0284964725285644,9.73545763843234e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,42111,0.0404674699205524,0.00964136546644761,0.0215703936063151,0.0593645462347897,2.71873019905232e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,42185,0.0736723807100634,0.00997498349580143,0.0541214130582926,0.0932233483618342,1.60466960212442e-13
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,42185,-0.0158979472434667,0.00934631475219201,-0.034216724157763,0.00242082967082965,0.0889685679395543
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,42185,-0.0333581953146977,0.00949769552825152,-0.0519736785500707,-0.0147427120793247,0.000445787642192312
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,42185,0.0352754948191837,0.00947124953901297,0.0167118457227183,0.0538391439156492,0.000196508785485487
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,42185,-0.0161922820288268,0.00952512933202077,-0.0348615355195875,0.0024769714619339,0.0891624631601076
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,42185,-0.00829657991591735,0.00916796600135807,-0.0262657932785792,0.00967263344674447,0.365506244092274
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,42185,-0.0396535212065687,0.00948334624989359,-0.0582408798563602,-0.0210661625567773,2.91555764894715e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,42185,-0.045075574457022,0.00954520787543529,-0.0637841818928751,-0.0263669670211688,2.35494785848146e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,42185,-0.0250108020293072,0.00927721177006681,-0.0431941370986381,-0.00682746695997622,0.00702768644155592
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,42185,0.0327232906747499,0.00940501890241779,0.014289453626011,0.0511571277234887,0.00050421966543843
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,42185,-0.0304748670362832,0.00924703391891053,-0.0485990535173479,-0.0123506805552186,0.000984504288537963
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,42185,-0.0245555744218601,0.00892719777340202,-0.0420528820577281,-0.00705826678599217,0.00595563486530478
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,42185,-0.0170760101120968,0.00879473478154972,-0.0343136902839343,0.000161670059740601,0.0522040826932047
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,42185,-0.0338641886210912,0.00932488021738057,-0.0521409538471571,-0.0155874233950253,0.000282711321793563
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,42185,0.0267289141370619,0.00901782623369034,0.00905397471902884,0.044403853555095,0.00304186778765204
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,42185,-0.00437142555974196,0.00877070720733322,-0.0215620116861151,0.0128191605666311,0.618201762422176
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,42185,-0.0472915766476991,0.00921748091313873,-0.065357839237451,-0.0292253140579472,2.92738647412188e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,42185,-0.0479610191921142,0.00934465548847267,-0.0662765439495207,-0.0296454944347078,2.89935105216031e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,42185,-0.0288379671715456,0.0081419289684154,-0.0447961479496398,-0.0128797863934514,0.000398574267413916
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,42185,0.0525314951659955,0.00909887779253221,0.0346976946926323,0.0703652956393586,7.93840947299125e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,42185,-0.0415099304731255,0.00854570227381505,-0.058259506929803,-0.024760354016448,1.20260561492417e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,42185,-0.0221688599582103,0.00896158831849249,-0.0397335730624556,-0.00460414685396499,0.0133819059222992
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,42185,-0.015792757495699,0.00883888914959166,-0.0331169802288987,0.00153146523750062,0.0740025305060623
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,42185,-0.0236108320180217,0.00823111734116421,-0.0397438220067036,-0.00747784202933989,0.00413078852290093
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,42185,0.0435154887240244,0.00902269114284306,0.025831014084052,0.0611999633639968,1.43024231291129e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,42185,-0.0501443445540557,0.00875183645966882,-0.0672979440150065,-0.0329907450931048,1.02815620502189e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,42185,-0.0246672896519418,0.00893688340192676,-0.0421835811197182,-0.00715099818416535,0.00578492841407427
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,42185,0.0263360225344577,0.00855498808402358,0.00956824588977152,0.0431037991791439,0.00208501740659383
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,42185,-0.0662250726267331,0.00954901266162416,-0.0849411374435165,-0.0475090078099498,4.23750270164044e-12
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,42185,0.0431072004479721,0.0087850391201109,0.0258885237725548,0.0603258771233895,9.36058302026504e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,42185,-0.0577518193392106,0.00900383655824848,-0.0753993389933776,-0.0401042996850436,1.46315486646578e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,42185,-0.00877504986084985,0.00889939888645516,-0.026217871678302,0.00866777195660226,0.324137298961039
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,42185,0.0672626977992377,0.00898263379492028,0.0496567355611939,0.0848686600372814,7.41898932097252e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,42185,-0.0762783093604651,0.00922276964883094,-0.0943549378721737,-0.0582016808487565,1.45530696340757e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,42185,0.0377502927979156,0.00875758782623012,0.0205854206585045,0.0549151649373266,1.6397289736347e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,42185,-0.104832607652473,0.00889646063703558,-0.122269670501063,-0.0873955448038833,6.77774841248656e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,42185,0.0285273948380385,0.00872013988321245,0.0114359206669421,0.0456188690091349,0.0010726893409392
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,42185,0.0964001606665848,0.00882591117074574,0.0791013747719231,0.113698946561246,1.17383041227733e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,42185,-0.0649197000208681,0.00877496399173213,-0.0821186294446631,-0.0477207705970731,1.46041336629635e-13
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,42185,0.0636521968986661,0.00893168475822749,0.0461460947725402,0.081158299024792,1.08097247257823e-12
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,42173,-0.0756374391585084,0.0095120864940971,-0.0942811286869387,-0.0569937496300781,1.98409693107919e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,42173,0.00433777104463197,0.00828680802964245,-0.0119043726934672,0.0205799147827312,0.600666208662163
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,42173,-0.0128833909576575,0.0077256507825723,-0.0280256664914992,0.00225888457618419,0.095415766051105
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,42173,0.0460313268817168,0.00987278948214358,0.0266806594967154,0.0653819942667182,3.15453143539833e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,42173,0.114292103948734,0.00926323541593219,0.0961361625335072,0.132448045363961,8.65877141972145e-35
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,42185,0.0778437839499371,0.00876745286084434,0.0606595763426822,0.095027991557192,7.60115328139266e-19
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,42185,-0.101040850739606,0.00924407362941971,-0.119159235053268,-0.082922466425943,1.07639698745008e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,42185,-0.100282441108819,0.00889600830890913,-0.11771861739428,-0.0828462648233567,2.41483751639302e-29
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,42185,-0.0221827843241114,0.00888013879124815,-0.0395878563549577,-0.004777712293265,0.0125005631124935
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,42185,0.092399133423055,0.00888859192683135,0.0749774932464656,0.109820773599644,3.23986680260039e-25
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,42185,0.0526704709674073,0.00951557257793465,0.0340199487146553,0.0713209932201592,3.16657933615193e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,42185,-0.0777650312170733,0.00948007247766765,-0.0963459732733019,-0.0591840891608447,2.55391365435352e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,42185,-0.0839441883353139,0.00900823153492167,-0.10160032214376,-0.0662880545268674,1.35771701255537e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,42185,0.0139507057873984,0.00989980611858374,-0.00545291420502572,0.0333543257798226,0.158801942731905
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,42185,0.0883083181825681,0.00933199526900729,0.0700176074553138,0.106599028909822,3.47850263218671e-21
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,42185,0.000400695554386841,0.00870819244091345,-0.0166673616298035,0.0174687527385772,0.963300061718269
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,42185,-0.0485420978723258,0.00862376180551377,-0.0654446710111328,-0.0316395247335188,1.84975720614287e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,42185,-0.0521898501069276,0.00850202330271114,-0.0688538157802415,-0.0355258844336138,8.56113926474525e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,42185,0.0240760086573443,0.0092092907547618,0.0060257987780112,0.0421262185366775,0.0089504615345578
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,42185,0.0883318521608538,0.00971570072803612,0.069289078733903,0.107374625587805,1.10883881118078e-19
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,52044,0.0101871653585408,0.00738710494811233,-0.00429156033975938,0.024665891056841,0.167893400774889
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,52044,0.00281535100924518,0.00718004404940981,-0.011257535327598,0.0168882373460884,0.694982156286341
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50493,0.00721782315301913,0.00686155285862143,-0.00623082044987887,0.0206664667559171,0.292846630221587
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50493,-0.000946085904164851,0.00747186096955839,-0.0155909334044993,0.0136987615961696,0.899242449322692
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50493,0.0132439684804873,0.0073967896028211,-0.00125373914104205,0.0277416761020167,0.0733870167411248
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50493,0.00473207313322153,0.00680285438666268,-0.00860152146463732,0.0180656677310804,0.48668604772562
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24009.Traffic intensity on the nearest road,52044,-0.0557760928193776,0.026857434737501,-0.108416664904879,-0.00313552073387566,0.0378357964908401
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24010.Inverse distance to the nearest road,52044,-5.92315021058786e-05,0.006458991448736,-0.0127188547416284,0.0126003917374167,0.992683264090587
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24011.Traffic intensity on the nearest major road,52044,0.00951074841724845,0.00643625222207335,-0.00310430593801531,0.0221258027725122,0.139505750386631
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24012.Inverse distance to the nearest major road,52044,0.00393763453565139,0.00653455677482535,-0.00887009674300629,0.0167453658143091,0.546789749944281
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24013.Total traffic load on major roads,52044,-0.0192903994588388,0.0187322790201736,-0.0560056663383791,0.0174248674207014,0.30311706857073
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24015.Sum of road length of major roads within 100m,52044,-0.0148993590619805,0.0181993967865542,-0.0505701767636266,0.0207714586396657,0.412981192125751
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,52044,0.0244569512635021,0.00741499321442322,0.00992356456323256,0.0389903379637716,0.000974132584817885
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,52044,0.0180119108199551,0.00741643865355533,0.00347569105898662,0.0325481305809235,0.0151627515019298
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,52044,0.025407917084825,0.00732739486042036,0.0110462231584011,0.0397696110112489,0.000526218692049905
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,52007,0.0388588065411199,0.00716519444653666,0.024815025425908,0.0529025876563317,5.90967811222742e-08
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24020.Average daytime sound level of noise pollution,52044,-0.00198364466302151,0.00644731485654032,-0.0146203817818405,0.0106530924557975,0.758336265214357
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24021.Average evening sound level of noise pollution,52044,-0.00192778350298124,0.00644771738442409,-0.0145653095764525,0.01070974257049,0.764952635447644
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24022.Average night-time sound level of noise pollution,52044,-0.00197728226966514,0.00644753964140879,-0.0146144599668264,0.0106598954274961,0.759095485271022
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,52044,-0.00198776085745349,0.00644741817499199,-0.0146247004804378,0.0106491787655308,0.757854228594046
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,52044,-0.00197167303157222,0.00644752225343388,-0.0146088166483026,0.0106654705851582,0.75975719595185
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2405.Number of children fathered,52033,-0.000100319388773241,0.0140793083814156,-0.0276957638163477,0.0274951250388013,0.994314936644903
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49521,-0.022742134193069,0.0076504497391306,-0.037737015681765,-0.00774725270437305,0.00295573964857376
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49521,0.0189905348658477,0.00687958915692683,0.00550654011827113,0.0324745296134243,0.00577778844028367
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24502.Water percentage, buffer 1000m",49521,-0.0153717561896838,0.00695179562379361,-0.0289972756123193,-0.00174623676704836,0.0270333031456947
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49521,-0.0156538322450134,0.00719308836628121,-0.0297522854429246,-0.00155537904710227,0.029549033116071
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49521,0.0128122247427676,0.00694934922027209,-0.000808499728965732,0.0264329492145009,0.065247100250923
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24505.Water percentage, buffer 300m",49521,-0.0190407967638567,0.0069882009673382,-0.0327376706598396,-0.00534392286787386,0.0064412135895985
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",52118,-0.0249326190905057,0.00732835705974581,-0.0392961989276075,-0.010569039253404,0.000669542369932929
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",52118,-0.01289695577946,0.00686351517469913,-0.0263494455218703,0.000555533962950338,0.0602486781356888
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24508.Distance (Euclidean) to coast,52118,0.0604093717528968,0.00647726068881131,0.0477139408028266,0.073104802702967,1.18921637540889e-20
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2867.Age started smoking in former smokers,35536,-0.00224351842743759,0.0117666981371155,-0.025306246776184,0.0208192099213088,0.848792248293152
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",37060,-0.0148085771654494,0.027630302378544,-0.0689639698273958,0.0393468154964969,0.592004283743041
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,37059,-0.0126085927790563,0.031615792948727,-0.0745755469585613,0.0493583614004487,0.690045645293364
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,37060,-0.00218336692811087,0.0295659421875701,-0.0601326136157482,0.0557658797595264,0.94113358426273
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",37048,-0.0224311794691904,0.0296698658429016,-0.0805841165212774,0.0357217575828968,0.449654905008932
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28739.Difficulty with standing for long periods,37065,0.00279286736482795,0.0254744481780755,-0.0471370510642001,0.052722785793856,0.912702191449929
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28740.Difficulty with taking care of household responsibilities,37082,-0.018873547401681,0.0296068727619576,-0.0769030180151179,0.0391559232117559,0.523834765016973
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28741.Difficulty learning a new task,37036,0.0214689887489642,0.0347304346142145,-0.0466026630948961,0.0895406405928246,0.536486126501545
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28742.Difficulty with joining in community activities,36610,-0.0355625492122361,0.0318680227942846,-0.098023873889034,0.0268987754645618,0.26448469379115
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28743.Difficulty with being emotionally affected by health problems,37028,-0.0199129137726748,0.0280075291224286,-0.074807670852635,0.0349818433072853,0.477113640706714
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,37088,-0.00421882336545565,0.0374203453241602,-0.0775627002008096,0.0691250534698983,0.910238218684748
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,34927,0.0191604520085929,0.0264423774036404,-0.0326666077025424,0.0709875117197281,0.468717171497413
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2897.Age stopped smoking,35528,0.0259209014564093,0.0123509833349167,0.0017129741199725,0.0501288287928461,0.035880228213191
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,36113,0.00660574672230263,0.0255710930359269,-0.043513595628114,0.0567250890727193,0.796160329577571
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,36113,-0.0168692280495965,0.0289789166056324,-0.073667904596636,0.0399294484974431,0.560502830927089
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,36113,0.257823867712299,0.0971641950450908,0.0673820454239213,0.448265690000677,0.00798326583575147
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,36113,-0.0343514281569024,0.0949121595321964,-0.220379260840007,0.151676404526203,0.717415541150175
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,36113,0.118342379163852,0.117541960144008,-0.112039862718404,0.348724621046109,0.314058683220016
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,36113,0.0860941935041648,0.105194379198496,-0.120086789724886,0.292275176733216,0.413137883757054
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,36113,-0.0192609985364066,0.0433437300085448,-0.104214709353154,0.0656927122803412,0.656782141363282
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,36113,-0.0390485210600623,0.0816140236904837,-0.19901200749341,0.120914965373286,0.632341334915004
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29002.Recent lack of interest or pleasure in doing things,36069,-0.00191329116748672,0.030043141210244,-0.0607978479395649,0.0569712656045915,0.949222919891394
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29003.Recent feelings of depression,36069,-0.00219236891917938,0.0298792172794791,-0.0607556347869584,0.0563708969485997,0.941510173040954
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",36074,0.0110051666906662,0.0235472520769569,-0.0351474473801692,0.0571577807615016,0.640252229254458
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29005.Recent feelings of tiredness or low energy,36075,-0.0247453027381557,0.0231296800116811,-0.0700794755610507,0.0205888700847393,0.284721101947259
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29006.Recent poor appetite or overeating,36081,-0.00716095134612959,0.0367458350295032,-0.0791827880039558,0.0648608853116966,0.845493825234198
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29007.Recent feelings of inadequacy,36057,0.00093856308560386,0.03262017002041,-0.0629969701543998,0.0648740963256075,0.977046822270733
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29008.Recent trouble concentrating on things,36076,0.0258834805951892,0.0311859212444753,-0.0352409250439823,0.0870078862343608,0.406580413280612
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,36074,-0.00269810311469402,0.0534665088101967,-0.10749246038268,0.102096254153292,0.959754444360772
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29010.Recent thoughts of suicide or self-harm,36054,-0.0347344127602304,0.0579195024517455,-0.148256637565652,0.0787878120451907,0.548723418551455
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29038#0.Substances taken for depression_None of options listed,35992,-0.049666017396703,0.0490217807400022,-0.145748707647107,0.0464166728537012,0.311025573644227
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),35992,-0.0266465284791599,0.089868633393644,-0.202789049930702,0.149495992972382,0.766852529907933
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),35992,-0.0405133319771609,0.0541446980101633,-0.146636940077081,0.0656102761227592,0.454338063796032
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),35992,0.136163629007346,0.162374065092501,-0.182089538573955,0.454416796588647,0.401732203353181
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),35992,-0.15220523188051,0.106991984708025,-0.361909521908239,0.0574990581472189,0.154898584839204
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),35992,0.0746489728380818,0.124701221332063,-0.169765420972762,0.319063366648926,0.549442905528317
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),35992,-0.177243977240336,0.128825446840297,-0.429741853047317,0.0752538985666451,0.168910996455607
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),35992,0.141276514667654,0.150629106972661,-0.153956534998762,0.43650956433407,0.348321412457918
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),35992,-0.000290105064718016,0.106166887013319,-0.208377203610823,0.207796993481387,0.997819826479791
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,35992,-0.0960538041863136,0.0461176729858147,-0.18644444323851,-0.00566316513411676,0.0373039179065279
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,35992,-0.162422187886683,0.0755034990618547,-0.310409046047918,-0.0144353297254473,0.0314937058609433
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,35992,0.0531692422410632,0.116695791225125,-0.175554508560181,0.281892993042308,0.64867475678242
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,35992,0.220166696688315,0.145736421902191,-0.0654766902399793,0.505810083616609,0.130902951982537
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,35992,0.0573033870196301,0.0861345944304477,-0.111520418064047,0.226127192103308,0.505893928208197
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,35992,-0.0304818209660787,0.133373966122258,-0.291894794565704,0.230931152633547,0.819229668650715
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,35992,0.0353508802866905,0.131228116850744,-0.221856228740768,0.292557989314149,0.787640981779733
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,35992,-0.0815356767819086,0.0744558926580785,-0.227469226391742,0.0643978728279252,0.273514222097655
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,35992,0.145652039869451,0.0703856120030597,0.00769624034345409,0.283607839395448,0.0385484915759322
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,35992,0.0526903393407271,0.105729276290014,-0.154539042187701,0.259919720869155,0.618251169089801
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29058.Recent feelings or nervousness or anxiety,35956,0.00239482898990588,0.0290511099115951,-0.0545453464368205,0.0593350044166322,0.934303027904372
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29059.Recent inability to stop or control worrying,35962,0.00490263035888939,0.0308713692932398,-0.0556052534558607,0.0654105141736395,0.873824249136239
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29060.Recent worrying too much about different things,35960,0.00204795640258562,0.0274508493780095,-0.051755708378313,0.0558516211834843,0.940531435874761
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29061.Recent trouble relaxing,35957,0.0104415402315276,0.0291960585529482,-0.0467827345322509,0.0676658149953061,0.720626543326884
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29062.Recent restlessness,35965,0.0479882401157731,0.0402397506836907,-0.0308816712242607,0.126858151455807,0.233080918839825
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29063.Recent easy annoyance or irritability,35953,0.0209539326468687,0.0280763615412879,-0.0340757359740556,0.075983601267793,0.455498375279448
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29064.Recent feelings of foreboding,35956,-0.0351366019923948,0.0349799372859435,-0.103697279072844,0.0334240750880545,0.315180981250953
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,35992,-0.111138340482432,0.058146079768196,-0.225104656828096,0.00282797586323219,0.055996413199347
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,35992,-0.228142383680751,0.0886378888633542,-0.401872645852925,-0.0544121215085767,0.0100761110255864
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',35992,-0.0863627809585589,0.121060608536215,-0.32364157368954,0.150916011772422,0.475630284247773
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,35992,-0.149124665945464,0.121814930396183,-0.387881929521982,0.0896325976310546,0.220919432106469
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#2.Symptoms of panic attack_Sweating,35992,-0.011445590457773,0.075520220760636,-0.159465223148619,0.136574042233074,0.879540775052236
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,35992,-0.0943990211308468,0.0947542548602748,-0.280117360656985,0.0913193183952917,0.319160815474947
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,35992,-0.0586525672030385,0.0901786769042777,-0.235402773935423,0.118097639529346,0.515451543446928
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,35992,-0.0969074207661199,0.0894789339929136,-0.27228613139223,0.0784712898599907,0.278835140656437
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,35992,-0.104387057177797,0.11295911414872,-0.325786920909289,0.117012806553694,0.355457321277145
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29076.Felt loved as a child,35925,-0.0253921227435926,0.0236301644869274,-0.0717072451379704,0.0209229996507852,0.282605410975845
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29077.Physically abused by family as a child,35937,0.00439818634353795,0.0304081489364954,-0.0552017855719931,0.063998158259069,0.885000342848592
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29078.Felt hated by family member as a child,35929,0.044600731951223,0.0343370542682955,-0.0226998944146362,0.111901358317082,0.194015809159347
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29079.Sexually molested as a child,35913,0.0931429913831867,0.0510368204068578,-0.00688917661425457,0.193175159380628,0.0680394704398594
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29080.Someone to take to doctor when needed as a child,35925,-0.032695519087905,0.0362615405347288,-0.103768138535974,0.0383771003601635,0.367268067163831
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35934,0.0459266713373589,0.0519093234462884,-0.0558156026173663,0.147668945292084,0.37632155645061
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35908,0.0109155772606378,0.0441433486523528,-0.0756053860979737,0.0974365406192493,0.804701813884893
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35946,0.0118245575398709,0.04980926591402,-0.0858016036516083,0.10945071873135,0.812355636672976
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35938,0.110685846704302,0.155809608367673,-0.194700985696337,0.41607267910494,0.477483870838942
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35931,0.077860884811061,0.096240882656801,-0.110771245196269,0.266493014818391,0.418529387141141
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29086.Experienced a violent or sexual assault,35952,-0.0199609758564539,0.0532292076845962,-0.124290222918262,0.0843682712053547,0.707670964073027
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29087.Experienced a life-threatening injury or illness,35943,-0.0387268033820042,0.0268257659179365,-0.0913053045811598,0.0138516978171514,0.148882359630338
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29088.Experienced a marital separation or divorce,35942,0.0010314376275341,0.0267664484169089,-0.0514308012696073,0.0534936765246755,0.969262396342313
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29089.Experienced the death of a spouse or partner,35953,-0.0256933553138578,0.0405849046823101,-0.105239768491186,0.05385305786347,0.526703283344758
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35946,-0.0210932717884002,0.0327888149381167,-0.085359349067109,0.0431728054903086,0.520045045377305
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29091.Frequency of drinking alcohol,35939,-0.0376586731220531,0.0215934749492853,-0.0799818840226522,0.00466453777854604,0.0812037782355554
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,35336,-0.0318518185853316,0.023033314736534,-0.0769971154689382,0.013293478298275,0.166754068867707
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,35356,-0.0450756510980766,0.0229568086741021,-0.0900709960993168,-8.0306096836423e-05,0.0496292922750122
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29104.Ever used cannabis,35933,-0.0456682059519482,0.0288705004001436,-0.10225438673623,0.0109179748323333,0.113731668715465
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29108.Ever thought that life not worth living,35907,0.0185631682563107,0.0291470517584609,-0.0385650531902726,0.075691389702894,0.524223100977145
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29109.Ever contemplated self-harm,35913,0.0626691491591641,0.041014974106616,-0.0177202000898032,0.143058498408131,0.126566273061228
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29111.Ever self-harmed,35925,0.108349352841696,0.0714131397609246,-0.031620401089716,0.248319106773109,0.12925462979941
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35926,-0.00321714678838447,0.0442111344206771,-0.0898709702529116,0.0834366766761427,0.941992885232035
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,36584,0.0434967453037501,0.118690361095125,-0.189136362442695,0.276129853050195,0.714022290796036
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,36584,-0.0630360637243002,0.0921423325592456,-0.243635035540422,0.117562908091821,0.4939216394889
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,36584,-0.0394344273747804,0.114881447550518,-0.264602064573795,0.185733209824234,0.731410456331663
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,36584,-0.0574891443303853,0.188276727881948,-0.426511530979003,0.311533242318232,0.760112228339615
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35916,-0.0364336022318318,0.0249885862234825,-0.0854112312298574,0.0125440267661939,0.144880787154663
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X29153.Pain or discomfort today,35930,0.0136298110336991,0.0229237368844856,-0.0313007132598928,0.0585603353272909,0.552147990712243
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29154.Anxiety or depression today,35930,-0.0408886064249361,0.0305533469817806,-0.100773166509226,0.0189959536593539,0.18085019138623
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29166.Frequency of confiding in someone close,35757,0.00569947350034846,0.0227531486739258,-0.038896697900546,0.050295644901243,0.802214364059825
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35913,0.00963519014256746,0.0241115975159793,-0.037623540988752,0.0568939212738869,0.689456845260461
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35913,-0.0195678834867744,0.0248926150132046,-0.0683574089126553,0.0292216419391065,0.431839108351495
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35913,0.0269107372350715,0.0264784065970277,-0.0249869396951028,0.0788084141652458,0.309506999555761
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35913,0.0513494433994858,0.036709333414095,-0.0206008500921404,0.123299736891112,0.161911878431611
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35913,0.0316097664997845,0.0728574518933419,-0.111190839211166,0.174410372210735,0.664404576726965
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35913,-0.0183652242445444,0.0268054572688333,-0.0709039204914577,0.0341734720023688,0.493283575045435
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35908,-0.00470888761419278,0.0281888441326913,-0.0599590221142677,0.0505412468858822,0.867336970298084
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35908,-0.0314497669146037,0.0441295645212402,-0.117943713376235,0.0550441795470271,0.47607343667275
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35908,0.0267984464592122,0.0508697934544182,-0.0729063487114475,0.126503241629872,0.59834520549283
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35908,0.13762630263756,0.062225491358675,0.0156643395745567,0.259588265700563,0.0270157987018992
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35908,0.104668118320223,0.100522436176806,-0.0923558565863167,0.301692093226763,0.297797988752012
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35908,-0.0186800998398662,0.0410524607972364,-0.0991429230024496,0.0617827233227171,0.649101197653854
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29171.Frequency of feeling 'in tune' with people,35732,0.0300067262398802,0.0279199986775144,-0.024716471168048,0.0847299236478084,0.282527723482166
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29172.Freuency of feeling that lacks companionship,35866,0.00275299471343649,0.026248688845148,-0.0486944354230537,0.0542004248499267,0.916472950197642
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29173.Frequency of feeling left out,35838,0.0262269393447431,0.0272147295394929,-0.027113930552663,0.0795678092421491,0.33522662851677
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29174.Frequency of feeling isolated from others,35874,0.0132508564325769,0.0278180280708964,-0.04127247858638,0.0677741914515338,0.633846048037617
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29175.Tendency to bounce back quickly after hard times,35923,0.0214799067347012,0.0224002728320871,-0.0224246280161895,0.065384441485592,0.337634382589117
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29176.Ability to make it through stressful events,35923,-0.0154303503504523,0.0217246431229606,-0.0580106508714551,0.0271499501705505,0.477559686560546
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29177.Quick recovery from stressful events,35923,0.0282840535338541,0.0223620348112839,-0.0155455346962624,0.0721136417639705,0.205974447470222
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29178.Hard to snap back when something bad happens,35923,-0.0146755764688197,0.0220015840115341,-0.0577986811314265,0.0284475281937871,0.504778063458698
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29179.Comes through difficult times with little trouble,35923,0.00945175741145636,0.0223317291501493,-0.0343184317228364,0.0532219465457491,0.67213010485192
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29180.Tendency to take a long time to get over setbacks,35923,-0.0193500908329743,0.0220051017447885,-0.0624800902527598,0.0237799085868112,0.379242748306733
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29181.General happiness,35884,0.00179608671211701,0.0227354344103095,-0.0427653647320895,0.0463575381563235,0.937035235356715
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29182.Belief that own life is meaningful,35790,0.00761785504795743,0.0230169843956022,-0.037495434367423,0.0527311444633378,0.740679298063238
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,34861,0.0247689555102455,0.0239831906308752,-0.0222380981262698,0.0717760091467609,0.301754649064705
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2946.Father's age,33552,-0.0169907043526367,0.0215281059166894,-0.0591857919493479,0.0252043832440744,0.430013276903747
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2966.Age high blood pressure diagnosed,35526,0.0144970970473542,0.0159256140316153,-0.0167171064546118,0.0457113005493202,0.362695645929774
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51674,0.0910025316681499,0.00688641879012806,0.0775051508394989,0.104499912496801,1.00532544728489e-39
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51674,0.00415498277980369,0.00741261742963803,-0.0103737473822868,0.0186837129418942,0.575124498495181
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30020.Haemoglobin concentration,51674,-0.0277437472566807,0.00780818590090832,-0.043047791622461,-0.0124397028909004,0.000381389860840222
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30030.Haematocrit percentage,51674,-0.00479099815958127,0.00766034265894872,-0.0198052697711208,0.0102232734519582,0.531695915250354
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30040.Mean corpuscular volume,51674,-0.0143117039262021,0.00684615504490683,-0.0277301678142195,-0.000893240038184721,0.0365862252270176
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51674,-0.0398692493249994,0.00686612887194602,-0.0533268619140136,-0.0264116367359852,6.45685093116074e-09
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51674,-0.0509171092560486,0.00666778328841372,-0.0639859645013395,-0.0378482540107578,2.32241970090223e-14
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51674,0.0356358890664622,0.00699225732947453,0.0219310647006921,0.0493407134322323,3.48759838696146e-07
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30080.Platelet count,51674,0.353238890833656,0.00642515483766537,0.340645587351831,0.36583219431548,0
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30090.Platelet crit,51674,0.321744603257901,0.00662402655415014,0.308761511211766,0.334727695304035,0
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51674,-0.148942762999545,0.00639455171379622,-0.161476084358585,-0.136409441640504,1.24483652922133e-118
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30110.Platelet distribution width,51674,-0.0946257012613016,0.00661928670140568,-0.107599503196057,-0.0816518993265464,3.67882687082742e-46
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30120.Lymphocyte count,51639,0.0445429499008004,0.00671458588117851,0.0313823615736905,0.0577035382279102,3.34498747183669e-11
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30130.Monocyte count,51639,0.0461302018739849,0.00672682097618452,0.0329456327606632,0.0593147709873066,7.17715527829357e-12
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30140.Neutrophill count,51639,0.0777076846456666,0.00681109952760224,0.0643579295715662,0.091057439719767,4.54213923242012e-30
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30150.Eosinophill count,51639,0.0408196937932908,0.0064977240236633,0.0280841547069108,0.0535552328796709,3.39889453932783e-10
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30160.Basophill count,51639,0.0960105516512535,0.0136575485428993,0.0692417565071709,0.122779346795336,2.12522169951142e-12
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30170.Nucleated red blood cell count,51639,-0.125869135151831,0.0687681157336495,-0.260654641989784,0.00891637168612186,0.0672118036520308
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30180.Lymphocyte percentage,51639,-0.0266845805291329,0.00664836564127639,-0.0397153771860347,-0.0136537838722312,5.9961974826334e-05
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30190.Monocyte percentage,51639,-0.0155773005623813,0.00665780934900337,-0.0286266068864279,-0.00252799423833467,0.0193075422551537
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30200.Neutrophill percentage,51639,0.0225859469706645,0.00655266237018175,0.00974272872510826,0.0354291652162207,0.000568206524776059
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30210.Eosinophill percentage,51639,0.014125143510525,0.00644678569004633,0.0014894435580342,0.0267608434630158,0.0284591224018244
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30220.Basophill percentage,51639,-0.00820989698589875,0.00673246484198232,-0.0214055280761841,0.00498573410438659,0.222686335614445
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51638,-0.127814327269903,0.0689121659885226,-0.262882172607407,0.00725351806760147,0.0636457659843942
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30240.Reticulocyte percentage,51286,0.036223207167646,0.0071130233526054,0.0222816813965394,0.0501647329387526,3.56164069324194e-07
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30250.Reticulocyte count,51286,0.0367044299111385,0.00717588700012548,0.0226396913908926,0.0507691684313845,3.1634844373513e-07
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30260.Mean reticulocyte volume,51286,-0.0168851059190643,0.00672496858648618,-0.0300660443485773,-0.00370416748955143,0.0120524105491267
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30270.Mean sphered cell volume,51286,0.00849256639341765,0.00675836627214982,-0.004753831499996,0.0217389642868313,0.208911274549885
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30280.Immature reticulocyte fraction,51286,0.0131126067134987,0.00700810724781997,-0.000623283492228401,0.0268484969192259,0.0613492795945922
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,51286,0.0316953272770908,0.00721070129168604,0.0175623527453861,0.0458283018087954,1.10970906817603e-05
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30300.High light scatter reticulocyte count,51286,0.0323333145640568,0.00723906561833371,0.0181447459521227,0.0465218831759909,7.98919784769264e-06
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30500.Microalbumin in urine,37077,0.00503946424339453,0.0106296145346088,-0.0157945802444387,0.0258735087312278,0.635443224880485
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51725,0.00351069351046982,0.00724025351733406,-0.0106802033835049,0.0177015904044446,0.62776220419818
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30520.Potassium in urine,51677,-0.000908783470223546,0.00676229918996082,-0.0141628898825468,0.0123453229420997,0.893095584977691
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30530.Sodium in urine,51690,-0.0110437376444349,0.00699838558897367,-0.0247605733988233,0.00267309810995348,0.114569947158981
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30600.Albumin,49524,0.050258755469652,0.00715834138947667,0.0362284063462777,0.0642891045930263,2.27020264178965e-12
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30610.Alkaline phosphatase,51250,0.0485158615753705,0.00702619209046592,0.0347445250780573,0.0622871980726837,5.1530631534827e-12
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30620.Alanine aminotransferase,51235,0.0202456195618319,0.00758177857898319,0.00538533354702488,0.035105905576639,0.00758377509196525
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30630.Apolipoprotein A,49461,-0.00493563039278645,0.0077709098657673,-0.0201666137296904,0.0102953529441175,0.525342843564462
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30640.Apolipoprotein B,51083,0.0707837111500181,0.00657376967089135,0.057899122595071,0.0836682997049651,5.6970784210964e-27
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30650.Aspartate aminotransferase,51172,-0.000294159684047793,0.00699588961066368,-0.0140061033209486,0.013417783952853,0.966461202173873
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30660.Direct bilirubin,49686,-0.0479997954711083,0.00710893371547792,-0.0619333055534451,-0.0340662853887716,1.49573686835314e-11
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30670.Urea,51233,-0.0158708683327997,0.00688487021701717,-0.0293652139581534,-0.00237652270744604,0.0211654691360427
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30680.Calcium,49515,0.0957343288163338,0.00706530386157793,0.0818863332476411,0.109582324385027,1.18906922862018e-41
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30690.Cholesterol,51253,0.0706309173563748,0.00662281742115431,0.0576501952109124,0.0836116395018373,1.71916921259665e-26
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30700.Creatinine,51241,-0.03723174478472,0.00858305750211195,-0.0540545374888594,-0.0204089520805806,1.44526277011388e-05
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30710.C-reactive protein,51170,0.0865672158004514,0.00732753786796353,0.0722052415792429,0.10092919002166,4.11145718241974e-32
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30720.Cystatin C,51259,0.0220009983825434,0.00794135971571748,0.00643593333973714,0.0375660634253497,0.00560275516289923
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30730.Gamma glutamyltransferase,51236,0.0585455130934801,0.00800708462033356,0.0428516272376263,0.0742393989493338,2.72519547075382e-13
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30740.Glucose,49490,0.025258909636871,0.00677269730958387,0.0119844229100866,0.0385333963636554,0.000192351998352036
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),51139,0.0292213108137065,0.00680249332954489,0.0158884238877985,0.0425541977396145,1.74890270148073e-05
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30760.HDL cholesterol,49502,-0.0228741201294782,0.00802642960311548,-0.0386059221515846,-0.00714231810737189,0.00437826225697951
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30770.IGF-1,51146,-0.0132279244272472,0.00703772801177322,-0.0270218713303227,0.000566022475828258,0.0601791644976696
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30780.LDL direct,51199,0.0649967099128504,0.00660983584041016,0.0520414316656465,0.0779519881600543,8.98767651576942e-23
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30790.Lipoprotein A,46673,0.00185759225820906,0.00728562098101385,-0.0124222248645781,0.0161374093809962,0.798751559017398
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30810.Phosphate,49461,0.0375267654767127,0.00693115047377437,0.023941710548115,0.0511118204053105,6.22365225789035e-08
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30830.SHBG,49370,-0.063216822867026,0.00921682278255702,-0.0812817955208378,-0.0451518502132142,7.1367213793974e-12
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30840.Total bilirubin,51158,-0.0624133453640845,0.00722686479506625,-0.0765780003624143,-0.0482486903657546,6.18503117142363e-18
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30850.Testosterone,51023,-0.0380152674340323,0.0113621932745301,-0.0602851662521114,-0.0157453686159532,0.00082189565133404
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30860.Total protein,49490,0.131337813498861,0.00697530020352494,0.117666225099952,0.14500940189777,1.9506145291061e-78
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30870.Triglycerides,51225,0.103466882634995,0.00692522044499208,0.0898934505628102,0.117040314707179,3.11495561351429e-50
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30880.Urate,51220,0.0298900164524268,0.00831974940591249,0.0135833076168383,0.0461967252880153,0.000328016087364474
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30890.Vitamin D,50557,-0.022795580265835,0.00749106337060888,-0.0374780644722284,-0.00811309605944161,0.00234480580456272
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X3137.Number of measurements made,49932,0.00228091372530681,0.0164235470054556,-0.0299092384053862,0.0344710658559998,0.889545732370926
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X3143.Ankle spacing width,42041,-0.0173272373310013,0.012302714384506,-0.0414405575246331,0.00678608286263044,0.15903351863785
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",42040,-0.00968984926702868,0.00895692403383038,-0.0272454203733362,0.00786572183927887,0.279348468876052
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X3146.Speed of sound through heel,42041,-0.018560131958032,0.0086488353127173,-0.0355118491709579,-0.00160841474510609,0.0318933087599029
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",42041,-0.0160605897175259,0.0087329873975979,-0.0331772450168177,0.00105606558176603,0.0659266902870369
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X3148.Heel bone mineral density (BMD),42022,-0.0144974186254535,0.0087810230355521,-0.0317082237751356,0.00271338652422858,0.0987631422507268
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X3526.Mother's age at death,42800,-0.00398738025241931,0.0086182677130275,-0.0208791849699532,0.0129044244651146,0.643610815313468
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32993,0.00920588586364817,0.0158708953553213,-0.0219010690327816,0.0403128407600779,0.561911795153671
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4100.Ankle spacing width (left),36209,-0.0436371932018563,0.0159331261288547,-0.0748661204144116,-0.012408265989301,0.0061812753636929
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),36207,-0.000644784880650846,0.0114836494201701,-0.0231527377441841,0.0218631679828825,0.955225315637617
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4103.Speed of sound through heel (left),36209,-0.0037340930042288,0.0109961997500239,-0.0252866445142755,0.0178184585058179,0.734181974719373
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",36209,-0.00358063995544957,0.0111489659920099,-0.025432613299789,0.0182713333888899,0.748095378525803
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4105.Heel bone mineral density (BMD) (left),36198,-0.00174413403582147,0.011211022024518,-0.0237177372038767,0.0202294691322337,0.876373621412746
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",36209,-0.0036000369475253,0.0111496585774751,-0.0254533677593765,0.0182532938643259,0.74679260536581
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4119.Ankle spacing width (right),36198,-0.0215935657468808,0.0155991056031391,-0.0521678127290335,0.0089806812352718,0.166312686779128
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),36197,0.000753271521087192,0.0115750241621846,-0.0219337758367947,0.0234403188789691,0.94811415253572
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4122.Speed of sound through heel (right),36198,0.00235785526896091,0.0109863805368377,-0.019175450583241,0.0238911611211628,0.830072320166839
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",36198,0.00205675876685578,0.0111774721697958,-0.019851086685944,0.0239646042196556,0.854011074029685
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4124.Heel bone mineral density (BMD) (right),36187,0.00547748227669478,0.0112238934610982,-0.0165213489070576,0.0274763134604472,0.625549916906648
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",36198,0.00205729675302652,0.0111774859996429,-0.0198505758062735,0.0239651693123266,0.853973495637129
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4194.Pulse rate,36589,0.0432986479352023,0.0103188035328534,0.0230737930108097,0.063523502859595,2.74499628642812e-05
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4195.Pulse wave reflection index,36589,-0.0184195852562217,0.0108203921656135,-0.0396275539008242,0.00278838338838077,0.0887374999289197
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4196.Pulse wave peak to peak time,36582,-0.0253653805193613,0.0119164106964946,-0.0487215454844909,-0.00200921555423183,0.0333171497985735
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4198.Position of the pulse wave peak,36589,0.0304708906263169,0.0128954715872606,0.00519576631528616,0.0557460149373475,0.0181556969509999
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4199.Position of pulse wave notch,36589,0.0244378413479407,0.0104695207424152,0.00391758069280698,0.0449581020030745,0.0196104793049098
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4200.Position of the shoulder on the pulse waveform,36589,0.0292915814330194,0.0131159738652146,0.00358427265719877,0.05499889020884,0.0255583718032606
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4269.Number of triplets attempted (left),36366,-0.0265376218838234,0.0689154224878762,-0.161611849960061,0.108536606192414,0.700192246862529
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4270.Volume level set by participant (left),36278,-0.0162154309366046,0.0218548587558419,-0.0590509540980547,0.0266200922248455,0.458134277034789
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4276.Number of triplets attempted (right),36372,-0.0842144091673239,0.0680403619280101,-0.217573518546224,0.0491447002115759,0.215860119937765
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4277.Volume level set by participant (right),36284,-0.00462959384001921,0.0217314612359083,-0.0472232578623995,0.0379640701823611,0.831304168459916
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X4288.Time to answer,36555,0.0334235778236641,0.0122942760750958,0.00932679671647635,0.0575203589308519,0.00656951824598263
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X4290.Duration screen displayed,36555,-0.00420150844735706,0.0114967116966479,-0.0267350633727869,0.0183320464780728,0.714782957714048
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X46.Hand grip strength (left),52280,-0.0117204853502655,0.00882531091456318,-0.0290180947428094,0.0055771240422783,0.184173222365541
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X47.Hand grip strength (right),52279,-0.0150394435382763,0.00871042462267447,-0.0321118757987183,0.00203298872216562,0.0842520655497588
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X48.Waist circumference,52337,0.049366662875512,0.0164694651996921,0.0170865110841154,0.0816468146669086,0.00272515780944623
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X4803.Tinnitus,36405,-0.0319942786727131,0.0250832359727483,-0.0811574211792997,0.0171688638338735,0.202161681513166
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X4825.Noisy workplace,36484,0.0500965501657283,0.0238546417858302,0.00334145226550107,0.0968516480659556,0.0357538946079654
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X4836.Loud music exposure frequency,36432,0.0422967879604118,0.0319533122648376,-0.0203317040786699,0.104925279999493,0.18563938304574
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X49.Hip circumference,52331,-0.0389222498463881,0.0121589312213649,-0.0627537550402632,-0.0150907446525129,0.00137072749362671
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X50.Standing height,52289,-0.0471453507971747,0.00922069932494477,-0.0652179214740665,-0.029072780120283,3.19565048113189e-07
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X5057.Number of older siblings,35549,0.0435038931978378,0.0232130365273774,-0.00199365839582191,0.0890014447914976,0.0609565479186902
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X51.Seated height,52183,-0.038678393984719,0.0080230779934523,-0.0544036268518856,-0.0229531611175525,1.43807421176051e-06
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5181.Ever had eye surgery,33953,-0.0113287944521516,0.0538424168301907,-0.116859931439325,0.0942023425350222,0.833358431423602
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5186.Duration visual-acuity screen displayed (right),33941,0.0167759848214071,0.0132296812356893,-0.00915419040054391,0.0427061600433581,0.204833005642332
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5188.Duration visual-acuity screen displayed (left),33937,0.0424056721967703,0.0136686197227546,0.0156151775401713,0.0691961668533692,0.00192954228986283
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5190.Duration at which refractometer first shown (right),33885,0.0346146058512921,0.013733259448073,0.00769741733306901,0.0615317943695151,0.0117482109565178
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5193.Duration at which refractometer first shown (left),33881,0.0347101026909942,0.0137892748444504,0.00768312399587151,0.061737081386117,0.0118591666668733
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5199.logMAR, initial (right)",33919,0.0622768878792807,0.027641024675374,0.00810047951554776,0.116453296243014,0.02429594729907
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5200.Final number of letters displayed (right),33919,0.103333779833748,0.17458973816899,-0.238862106977473,0.445529666644969,0.553965296150123
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5201.logMAR, final (right)",33859,0.0206127651167977,0.0131347579635625,-0.00513136049178483,0.0463568907253803,0.116631308094737
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5202.Number of rounds to result (right),33919,0.0434227287936304,0.0260056283895055,-0.00754830284980043,0.0943937604370612,0.0950290892787262
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5206.logMAR, initial (left)",33914,0.0477480584526447,0.0272915480534575,-0.00574337573213204,0.101239492637421,0.0802529004118357
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5207.Final number of letters displayed (left),33914,0.185629231152272,0.172707464217595,-0.152877398714214,0.524135861018758,0.282504674691729
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5208.logMAR, final (left)",33868,0.00963873506640692,0.0132932462287656,-0.0164160275419737,0.0356934976747876,0.468432016216914
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5209.Number of rounds to result (left),33911,0.0664471074841584,0.0261007512992837,0.0152896349375624,0.117604580030754,0.0109310567038246
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",33712,-0.00320742154160772,0.0131360903720171,-0.0289541586707612,0.0225393155875458,0.807109999531081
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",33712,0.00966930171031603,0.0128811924572226,-0.0155778355058402,0.0349164389264722,0.452896254707432
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5256.Corneal hysteresis (right),33712,0.0227149004940818,0.0133378012281232,-0.00342718991303976,0.0488569909012033,0.0886200865616475
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5257.Corneal resistance factor (right),33712,0.0252165724815797,0.0131426496157247,-0.000543020765240706,0.0509761657284002,0.0550801493479428
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",33685,0.011879437553183,0.0132775761143718,-0.0141446116309857,0.0379034867373517,0.370990219269612
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",33685,0.0219016055059811,0.0131277037596391,-0.00382869386291143,0.0476319048748737,0.0953078201822081
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5264.Corneal hysteresis (left),33685,0.0127270806726345,0.0132134633993185,-0.0131713075900297,0.0386254689352987,0.335497798748601
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5265.Corneal resistance factor (left),33685,0.0232048427213541,0.0131259896042094,-0.00252209690289628,0.0489317823456045,0.0771451511825795
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34627,0.0503310162689798,0.116547320010783,-0.178101730952156,0.278763763490115,0.665865537266952
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52268,-0.045658783987928,0.0359357000595299,-0.116092756104607,0.0247751881287507,0.203894534878756
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52268,-0.0103582076048014,0.0415899279059385,-0.0918744663004409,0.0711580510908381,0.803319875908891
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52268,0.0422875429028496,0.102656557354563,-0.158919309512094,0.243494395317794,0.680392839222935
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52268,-0.0282289628592473,0.0163959787451481,-0.0603650811997376,0.00390715548124307,0.0851368746741685
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52268,0.0248478118523826,0.0151952281046747,-0.00493483523277989,0.0546304589375451,0.10201249831813
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38966,-0.0181195765035479,0.0195178984332903,-0.0563746574327969,0.020135504425701,0.353244061659246
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38966,-0.013969326834249,0.0605549463464577,-0.132657021673306,0.104718368004808,0.817561398052394
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38966,-0.00539787543485115,0.037541010569006,-0.078978256150103,0.0681825052804007,0.885672175747767
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38966,0.0686859268535571,0.0226487825454494,0.0242943130644763,0.113077540642638,0.00243012611922676
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52341,-0.00676668303225678,0.034693485376923,-0.0747659143710258,0.0612325483065123,0.845361821185079
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52341,-0.00676668303225678,0.034693485376923,-0.0747659143710258,0.0612325483065123,0.845361821185079
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52341,0.0447240480537199,0.0252646318624103,-0.00479463039660418,0.094242726504044,0.0767027276311627
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52341,0.00617466154575219,0.044481684125557,-0.0810094393403395,0.0933587624318439,0.889598644806516
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52341,0.26163216193655,0.105542949233344,0.0547679814391963,0.468496342433903,0.0131851054933746
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52341,0.128874558778784,0.0732266200387743,-0.0146496164972137,0.272398734054782,0.0784306226197832
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52341,0.187067902467597,0.11216106969655,-0.0327677941376405,0.406903599072834,0.0953585850754188
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52267,0.0150985256061805,0.0224076735701297,-0.0288205145912737,0.0590175658036347,0.500438382448258
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52267,0.0511169120487074,0.0398169495511182,-0.0269243090714844,0.129158133168899,0.199225283643289
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52267,0.0306845203474946,0.0205139083580867,-0.00952274003435529,0.0708917807293445,0.134721450470314
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52267,0.0140591862898922,0.0303643469887521,-0.0454549338080619,0.0735733063878464,0.64335697160427
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52267,0.0555092189815749,0.030718884494014,-0.00469979462669254,0.115718232589842,0.0707739850200868
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52267,0.00206265429818158,0.0172913055788193,-0.0318283046363042,0.0359536132326673,0.905047788588863
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,37145,-0.115311671785184,0.0320546335770963,-0.178138753596292,-0.0524845899740749,0.000323294426956476
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,37145,-0.0929657391521636,0.0305252812475365,-0.152795290397335,-0.0331361879069921,0.00232976354599439
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,37145,0.0240596260998814,0.0444606693091317,-0.0630832857460167,0.111202537945779,0.588422413584007
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,37145,0.0922167711767667,0.0330966167186069,0.0273474024082972,0.157086139945236,0.00534327242719404
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52221,-0.024993174201414,0.0606987936147929,-0.143962809686408,0.0939764612835801,0.680521023609506
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52221,0.0589720846327543,0.0756373502561189,-0.0892771218692387,0.207221291134747,0.435593640006271
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52221,-0.183922875823319,0.148753501907206,-0.475479739561443,0.107633987914805,0.216312104675475
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52221,0.0320319660606891,0.143862971379707,-0.249939457843536,0.314003389964914,0.823805107152149
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52221,0.129327183061802,0.0577403311113844,0.0161561340834887,0.242498232040115,0.0251127359734326
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52221,0.116723187882888,0.0675214893387478,-0.0156189312210573,0.249065306986834,0.0838790793864088
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52221,0.0138795751313825,0.0284722443883719,-0.0419260238698263,0.0696851741325914,0.625924592130194
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",35707,0.0151055022509128,0.0488738248830902,-0.0806871945199439,0.11089819902177,0.757276262196665
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",35707,0.0365721362780477,0.0479604156254244,-0.0574302783477841,0.13057455090388,0.445758099018779
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",35707,-0.0271204914540011,0.0679768881643513,-0.16035519225613,0.106114209348127,0.689929980379146
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",35707,0.073173988065555,0.0246070441912145,0.0249441814507745,0.121403794680335,0.00295219845835824
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",38858,-0.0710745232971686,0.0209055428259396,-0.11204938723601,-0.0300996593583269,0.00067693748404912
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",38858,0.0331065075615378,0.0231250535704908,-0.0122185974366242,0.0784316125596997,0.152280364997083
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",38858,0.0663613897401135,0.0204595243653346,0.0262607219840577,0.106462057496169,0.0011842987416909
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",38859,0.0242462161810584,0.0478451217830092,-0.0695302225136396,0.118022654875756,0.612330856938541
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",38859,-0.0129530173182804,0.0284502032512495,-0.0687154156907294,0.0428093810541687,0.648912169049658
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",38859,0.0162364726473453,0.0513052481478583,-0.084321813722457,0.116794759017148,0.751653699124824
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52267,-0.00806749980748479,0.0446212405779428,-0.0955251313402526,0.0793901317252831,0.856526471653845
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52267,0.0128585036178937,0.0358862242874724,-0.0574784959855523,0.0831955032213397,0.720112225097607
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52267,-0.00678156553229889,0.0706655499935653,-0.145286043519687,0.131722912455089,0.923547541493597
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52267,-0.00122023474620986,0.0400316774847108,-0.0796823226162431,0.0772418531238234,0.975683121747358
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52267,0.00706982296099539,0.0410152356519127,-0.0733200389167534,0.0874596848387442,0.863147616064186
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52267,0.0348432430260633,0.0492638226020344,-0.061713849273924,0.131400335326051,0.479400381829627
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52267,-0.0396303513915051,0.0143535013510081,-0.0677632140394809,-0.0114974887435293,0.00576649489468723
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34215,-0.00265195348656564,0.0354775463417256,-0.0721879443163479,0.0668840373432166,0.940416132787187
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34215,-0.0432607179680528,0.0423330821761989,-0.126233559033403,0.0397121230972971,0.306866205380597
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34215,-0.0179169034240746,0.0315926683144821,-0.0798385333204596,0.0440047264723104,0.570653834508045
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34215,0.00786110571417721,0.0280657466817525,-0.0471477577820578,0.0628699692104122,0.779414107665275
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52377,0.0517131500740683,0.0174806238928723,0.0174511272440386,0.0859751729040981,0.0030963273653335
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52377,0.203223441416989,0.057021609932628,0.0914610859490381,0.31498579688494,0.000365999814069312
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52377,-0.0280005869943466,0.0153619275978903,-0.0581099650862117,0.00210879109751845,0.0683574316435493
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52377,0.00120098696997836,0.0143515826360293,-0.0269281149966391,0.0293300889365958,0.933308985435239
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52377,0.0252380749588817,0.0242814235952286,-0.0223535152877663,0.0728296652055297,0.298630016377577
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52377,0.0309400259482473,0.0219135942361239,-0.0120106187545556,0.0738906706510501,0.157989507585802
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52377,0.00335719407410309,0.0154787811712144,-0.0269812170214771,0.0336956051696833,0.828295870083113
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52377,0.0143641411998441,0.0501262970757597,-0.0838834010686449,0.112611683468333,0.774452513892556
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,45175,-0.025881538944077,0.015925932056226,-0.0570963657742798,0.00533328788612591,0.104156162076371
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,45175,0.0217060807113878,0.0156678883420583,-0.00900298043904658,0.0524151418618221,0.165952964513323
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,45175,-0.0216657792025583,0.0202752016591205,-0.0614051744544344,0.0180736160493178,0.285272209522769
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,45176,-0.0107453221403836,0.0315794009260547,-0.0726409479554508,0.0511503036746835,0.733662302484375
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,45176,0.00464665459542515,0.0179346218676193,-0.0305052042651087,0.039798513455959,0.795570161184314
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,52148,-0.000918679281619949,0.0165042244580788,-0.0332669592194545,0.0314296006562146,0.955610523985681
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,52148,0.00653780735750497,0.012970794283374,-0.018884949437908,0.031960564152918,0.614237539536576
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,52148,0.0190699876174341,0.0146584948710691,-0.0096606623298613,0.0478006375647296,0.193287862514661
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,52148,0.0247437698105048,0.0223859383766688,-0.0191326694077661,0.0686202090287757,0.269029453536264
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),52171,0.0136112586115413,0.0139592851748968,-0.0137489403312565,0.0409714575543391,0.329536311934281
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,52171,-0.00635077983115676,0.0194907689173014,-0.0445526869090675,0.031851127246754,0.744551889257859
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52267,0.0208792376424659,0.0142306899992554,-0.0070129147560746,0.0487713900410065,0.142335531918339
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52267,-0.00290584378754889,0.0178475332201966,-0.0378870088991343,0.0320753213240365,0.870665590590475
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52267,0.00393837561513711,0.0380889544302243,-0.0707159750681026,0.0785927262983768,0.91764685232381
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52267,-0.0429759829951392,0.0349753521825042,-0.111527673272847,0.025575707282569,0.219177567116896
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52267,0.0605404590708575,0.0421380566030026,-0.0220501318710277,0.143131050012743,0.150811662790888
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52267,0.00948092680432007,0.0435129248041693,-0.0758044058118517,0.0947662594204919,0.827518566380997
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",42041,-0.0160616760443867,0.00873301127516416,-0.0331783781437085,0.00105502605493501,0.0659091366803539
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X864.Number of days or week walked 10+ minutes,51897,0.0140223752143532,0.0122318173141161,-0.00995198672131432,0.0379967371500207,0.251647551334468
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X874.Duration of walks,49222,-0.00402390118100657,0.00667997817791884,-0.0171166584097275,0.00906885604771436,0.54692625652177
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,51298,0.0155440794914837,0.0118199587687664,-0.00762303969529838,0.0387111986782657,0.188499487142157
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X894.Duration of moderate activity,46489,0.00817142265839045,0.0141634627645154,-0.0195889643600597,0.0359318096768406,0.563989420822619
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X90087.No-wear time bias adjusted average acceleration,33348,0.0162530630709154,0.0149615922459224,-0.0130716577310926,0.0455777838729233,0.277392997271465
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,51222,-0.00994095139739721,0.0120519758003081,-0.0335628239660011,0.0136809211712067,0.409471148636842
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X914.Duration of vigorous activity,42126,0.00113126421310751,0.00802945155052183,-0.0146064608259153,0.0168689892521303,0.887959453393049
